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Key physicochemical properties determining the developability of a drug include solubility, 
dissolution rate, lipophilicity and pKa. Not only do these properties affect synthesis and solid 
form optimization, choice of administration route, processability and formulation strategies; 
they also greatly influence, directly or indirectly, the absorption, distribution, metabolism, 
excretion, toxicity and efficacy of drugs. However, miniaturized methods that would enable 
small-scale determination of these fundamental properties in an accurate and rapid way, are 
lacking. Image-based microscopy could provide an opportune method for non-specific, rapid 
and miniaturized applications. 
First, the applicability of image-based microscopy and single-particle analysis in drug 
dissolution rate measurement was evaluated. This was done by comparing image analysis data 
with traditional UV spectrophotometric data of individual dissolving drug pellets. It was found 
that dissolution rates obtained by image analysis and UV spectrophotometry were practically 
identical. 
 Next, a single-particle trap flow-through device was developed, wherein it is possible to 
continuously monitor individual drug particles under constant flow conditions. Based on the 
promising results of image-based dissolution rate analysis, the possibility of acquiring the 
intrinsic dissolution rate from individual freely rotating particles, trapped inside the flow 
through device, was evaluated. It was found that image analysis can be used for rapid real-time 
determination of intrinsic dissolution rates from continuously changing effective surface areas 
of dissolving individual micro-particles.  
The method was then further extended to determine the equilibrium solubility of drugs. 
Based on the diffusion layer dissolution rate model, solubility is the rate limiting factor of 
dissolution and can therefore be determined. While solubility is generally determined from 
bulk solutions after long incubation times, it was shown that the equilibrium solubility can be 
rapidly determined from individual pure-substance particles by means of the diffusion layer 
theory and image analysis.  
Finally, the single-particle method was further miniaturized and a second device 
developed, in order to allow imaging of individual powder crystals. It was shown that 
dissolution rate and solubility can be acquired from individual nanogram crystals. The single-
particle method was further extended to acquire pKa, logP and logD of the studied substances, 
using aqueous buffers, simulated physiological solutions and organic solvents. Using this 
method and device, it is possible to acquire a complete pH-solubility profile for an unknown 
material of unknown composition, with individual measurements of less than 30 seconds.  
In summary, these results strongly suggest that image-based analysis of materials could 
be applied in high-throughput experimentation (HTE) applications. The possibility of 
acquiring solubility, dissolution rate, lipophilicity and pKa using a single analytical method, 
could significantly simplify and speed up accurate data acquisition. This in turn, could lead to 
faster and more informed decision-making and, ultimately, better and more affordable drugs. 
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1 Introduction 
The process of bringing an new molecular entity (NME) to the market requires approximately 
13.5 years with estimated research and development (R&D) costs in the range of US $0.8 
billion to US $2.7 billion (Paul et al. 2010; Munos 2009; Kola & Landis 2004; DiMasi et al. 
2003). These costs have been growing exponentially for the past 60 years reaching US $50 
billion in collective annual R&D spending during the last years (Paul et al. 2010; Munos 2009). 
Simultaneously, R&D productivity has not been growing at the same rate, with the number of 
approved new drugs remaining essentially constant during this period (Munos 2009). 
However, following a decade of decreasing NME output, R&D productivity has been showing 
signs of recovery during the last years, with a new high for the past two decades of 45 approved 
new drugs on the US market in 2015 (Mullard 2016; Smietana et al. 2015).  
Nonetheless, a concurrent decrease in the actual and forecasted sales as well as a strong 
public and political pressure on decreasing drug spending, will undoubtedly reduce the R&D 
returns of this recent positive upswing in productivity (Smietana et al. 2015; Munos 2009; Kola 
& Landis 2004). In an environment of intense competition the pharmaceutical industry is thus 
continuously forced to find new ways to increase R&D productivity and returns (Cook et al. 
2014; Paul et al. 2010; Munos 2009; Kola & Landis 2004; DiMasi 2002). The fact that the 
pharmaceutical industry has not been able to increase the NME output since the 1950s, while 
R&D spending has soared, indicates that the rate of innovation has been barely enough to 
sustain the R&D process (Munos 2009). 
In order to reduce R&D costs, a bolder implementation of novel technologies and 
practices that result in faster development, through more informed decision-making regarding 
development projects, is required (Smietana et al. 2015; Munos 2009; DiMasi 2002). An 
increase in R&D productivity in turn will bring higher returns to the companies and ultimately 
cheaper drugs to patients, as returns translate into new R&D investments, thus affecting the 
output and price of new medicines (Kola & Landis 2004; DiMasi 2002). Currently only around 
11% of NMEs entering the development process make it through to regulatory approval and 
only 30% of these recover their initial R&D investment (Kola & Landis 2004). 
The pharmaceutical industry is on the other hand highly and increasingly regulated, 
making the implementation of novel practices more challenging (Paul et al. 2010; Munos 
2009). This is especially true for the expensive later clinical (Phase II and Phase III) stages of 
the development process (Paul et al. 2010). However, the preclinical and drug discovery phases 
are favorable for implementation of new technologies, as the information produced during 
these phases is mostly intended for in-house decision making, avoiding the requirement for  
regulatory compliance. The disproportional distribution of resources toward late-stage 
development, instead of the earlier discovery research phase has been identified as one of the 
possible root causes of the poor R&D productivity of the last decade (Paul et al. 2010). The 
benefit of a more efficient preclinical drug discovery phase is twofold: first, it accounts for 32% 
of NME development costs; second, and more importantly, it will reduce downstream attrition 
and costs accrued by later stage development failures (Smietana et al. 2015; Paul et al. 2010; 
Kola & Landis 2004; Gardner et al. 2004; DiMasi 2002).  
However, quality cannot be sacrificed for quantity regarding the data produced by novel 
technologies introduced for early decision-making (Cook et al. 2014; Paul et al. 2010). For 
example, the vastly increased number of leads generated by high-throughput screening (HTS) 
and combinatorial chemistry did not translate into an increase in NME output (Cook et al. 
2014; Alsenz & Kansy 2007). Instead, it led to increasing R&D costs and increasingly poor 
physicochemical properties, such as low solubility and high lipophilicity and molecular weight 
(MW) of candidate development compounds (Alsenz & Kansy 2007; Gardner et al. 2004).  
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A shift toward higher quality and more holistic data acquisition has therefore been 
introduced into the R&D decision-making process (Cook et al. 2014; Alsenz & Kansy 2007; 
Leeson & Springthorpe 2007; Gardner et al. 2004). Key physicochemical properties 
determining the developability of a drug include pKa, solubility, dissolution rate and 
lipophilicity. These properties not only affect synthesis and solid form optimization, choice of 
administration route, processability and formulation strategies; they also greatly influence the  
pharmacokinetics [PK = absorption, distribution, metabolism and excretion (ADME)] of a 
compound (Waring 2010; Tong et al. 2009; Alsenz & Kansy 2007; Gardner et al. 2004; Merkle 
& Jen 2002; Kerns 2001). Furthermore, these parameters are determinants of 
pharmacological efficacy, and are directly and indirectly connected to safety issues as well as 
NME attrition (Morgan et al. 2012; Gleeson 2008; Alsenz & Kansy 2007; Leeson & 
Springthorpe 2007).  
Current state of the art methods for physicochemical characterization of drugs have not 
been able to provide reliable means for high throughput experimentation (HTE). Especially for 
solubility measurement, there appears to be a discrepancy between throughput, substance 
consumption and accuracy. Instead, computational methods are used in early discovery, due 
to the lack of experimental methods capable of accommodating the requirements for 
throughput and low materials consumption (Tetko et al. 2009; Gardner et al. 2004). These in 
silico methods are, however, often inaccurate and challenging to implement due to the vast 
dimensionality of the possible chemical space of drug molecules (Balogh et al. 2012; Tetko et 
al. 2009; Mannhold et al. 2009; Jorgensen & Duffy 2002). The biggest issue with in silico 
models is, however, that they rely on experimental input parameters for accurate prediction.  
This dissertation focuses on investigating and implementing image-based microscopy as 
a potential analytical method for physicochemical characterization of drugs. The non-
specificity and potential for rapid data acquisition with automated analysis, makes image-
based analysis a promising method for accurate high-speed applications. In addition, two new 
miniaturized flow-through devices are introduced in this work. By means of these devices it is 
demonstrated that fundamental physicochemical properties, such as solubility, dissolution 
rate, lipophilicity and pKa can be determined from individual particles, in a fast, robust and 
cost-efficient way. 
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2 Review of the literature 
 
2.1 Physicochemical equilibria and kinetics 
 
In the simplest terms, the distribution of molecules and particles between two regions, phases 
or states in a system is described by the Boltzmann distribution (Israelachvili 1992). At 
equilibrium, the total free energy per molecule or particle, known as the chemical potential (µ), 
in the system is uniform,  
 
µ1 = µ2                                                                                                                                                (1) 
  
and the Boltzmann distribution is expressed as, 
 
µ1
𝑖 + 𝑘𝐵𝑇𝑙𝑛𝑋1 = µ2
𝑖 + 𝑘𝐵𝑇𝑙𝑛𝑋2                                                                                                     (2) 
 
where µ1
𝑖  and µ2
𝑖  are the energies and 𝑋1  and 𝑋2  are the concentrations of the molecules or 
particles in the two regions, phases or states in the system, 𝑘𝐵 is the Boltzmann constant and 
𝑇 is the absolute temperature (Israelachvili 1992).  
In this chapter the three generally expressed thermodynamic equilibria, in relation to 
drug molecules, will be presented. These are the ionization constant, solubility and 
partition/distribution coefficient. In addition to these, the kinetic rate of dissolution, which is 
a physicochemical property widely applicabile to drugs, will be presented.  The reader should 
bear in mind that the equations presented in this chapter are often approximate, semiempirical 
and limited to ideal systems and, therefore, only model simple cases such as monoprotic acids 
and bases, monovalent salts and nonelectrolytes in simple solvents. The intent here is, however, 
not to give a comprehensive review, but to convey the general basis of and the relationships 
between the most central physicochemical properties, revisited in later chapters of this thesis.  
 
 
2.1.1 Charge state 
 
Most drug molecules are weak acids or bases and their charge state, i.e. degree of dissociation 
in solvents, will therefore strongly depend on the pH of the solvent (Avdeef 2001). The ratio 
between dissociated and undissociated species will further have implications on other kinetic 
and thermodynamic parameters as will be reviewed in subsequent chapters. The 
thermodynamic constant describing the acid-base equilibrium is called the ionization constant 
(pKa). The pKa is the pH at which the concentrations of the dissociated and undissociated 
species are equal and is expressed by the well-known Henderson-Hasselbalch relations, 
 
𝑝𝐾𝑎 = 𝑝𝐻 + 𝑙𝑜𝑔 (
[𝐻𝐴]
[𝐴
−
]
)                                                                                                                   (3) 
 
for an acid and, 
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𝑝𝐾𝑎 = 𝑝𝐻 + 𝑙𝑜𝑔 (
[𝐵𝐻+]
[𝐵]
)                                                                                                             (4) 
 
for a base, where the symbols within brackets denote the concentration of the dissociated and 
undissociated species of the acid HA and base B, respectively.  
 
 
2.1.2 Solubility  
 
Solubility is the thermodynamic equilibrium determined by the opposite kinetic rates of 
dissolution and precipitation at constant volume, pressure and temperature (Kerns & Di 2008; 
Sugano et al. 2007; Bhattachar et al. 2006). In the simplest way, solubility can be expressed 
by the Boltzmann distribution (Eq. 2) as the state where the chemical potential of molecules in 
the solid and dissolved molecules in the liquid is uniform,  
 
𝑋𝑆 = 𝑒𝑥𝑝 [
−(µ2
𝑖 −µ1
𝑖 )
𝑘𝐵𝑇
]                                                                                                                     (5) 
 
where 𝑋𝑆 denotes the saturation concentration in mole fractions (Israelachvili 1992). Starting 
from the Boltzmann distribution a General Solubility Equation (GSE) for the solubility of a 
nonelectrolyte in water (𝑆𝑊) has been derived, 
 
𝑙𝑜𝑔𝑆𝑊 = 0.5 − 𝑙𝑜𝑔𝑃 − 0.01(𝑀𝑃 − 25)                                                                                                             (6) 
 
where 𝑀𝑃 is the melting point of the dissolving solid in degrees Celcius (Jain & Yalkowsky 2001; 
Ran et al. 2001; Yalkowsky & Valvani 1980). The partition coefficient (logP) is used here to 
describe the difference in polarity between the solute and water, i.e. the anticipated strength 
of adhesive interactions, and 𝑀𝑃 is used as a measure of the energy required to dissociate 
molecules and break the cohesive forces in the crystal lattice (Jain and Yalkowsky 2001). The 
magnitude of the difference between the adhesive and cohesive forces will generally be 
predictive of the solubility. The solubility of a dissociated salt is more complex and can be 
expressed by the Boltzmann distribution (Eq. 2) as, 
 
𝑋𝑆 = 𝑒𝑥𝑝 [
−𝑒2
4𝜋𝜀0𝜀(𝑎++𝑎−)𝑘𝐵𝑇
]                                                                                                    (7) 
 
where 𝑒 is the elementary charge, 𝜀0 is the vacuum permittivity, 𝜀 is the dielectric constant of 
the solvent and 𝑎+ and 𝑎− are the respective ionic radii of the positive and negative species 
(Israelachvili 1992).  
While solubility in itself is an equilibrium event, experimentally determined solubilities 
can produce different values for the same substance depending on the starting solid form and 
the measurement procedure (Sugano et al. 2007). The term solubility generally refers to 
thermodynamic equilibrium solubility, which is the solubility of the most stable crystal form 
in a specific environment (Kerns & Di 2008; Sugano et al. 2007; Bhattachar et al. 2006). For 
this equilibrium to be established, incubation times of several hours to days are generally 
required (Alsenz & Kansy 2007; Sugano et al. 2007).  
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Apparent solubility, on the other hand, signifies the solubility of a metastable or 
unstable solid form (Sugano et al. 2007; Bhattachar et al. 2006). Such apparent equilibria can 
occur in experiments where the starting material is a cocrystal, solvate, salt or meta-/unstable 
form, and the incubation times are not long enough to achieve crystal formation and 
equilibration with the most stable crystal polymorph (Sugano et al. 2007; Alsenz & Kansy 2007; 
Huang & Tong 2004). All unstable and metastable solid forms will eventually recrystallize to 
the most stable crystal form, and thus the solid form with the lowest solubility (Bhattachar et 
al. 2006). The apparent solubility is, therefore, always a case of sustained supersaturation. 
A special case of apparent solubility is the kinetic solubility. The kinetic solubility is a 
measure of precipitation tendency, often in cosolvent systems (Sugano et al. 2007; Alsenz & 
Kansy 2007; Lipinski et al. 1997). The starting material in these measurements is dissolved 
material and the onset of precipitation, when adding to an antisolvent, is assumed as the 
solubility. According to the Ostwald ‘rule of stages’, the precipitate formed in such a process is 
often amorphous or a metastable polymorph and will therefore significantly overestimate the 
equilibrium solubility (Ostwald 1897).  
For electrolytes, two further special cases of solubility exist, i.e. the native (𝑆𝑁) and the 
intrinsic solubility ( 𝑆0 ). The native solubility is the solubility of an ionizable compound 
measured under unbuffered conditions. The final equilibrium pH in such measurements may 
vary significantly from the initial pH due to self-buffering effects (Serajuddin & Jarowski 1985). 
The intrinsic solubility again, is the solubility of the unionized form of an electrolyte under 
buffered conditions (Sugano et al. 2007). For ionizable molecules the intrinsic solubility is thus 
measured at a pH, where the molecule does not dissociate. Through the Henderson-
Hasselbalch equations (Eqs. 3 and 4) the relationship between equilibrium solubility, intrinsic 
solubility, pKa and pH can be expressed as,  
 
𝑆 = 𝑆0(10
𝑝𝐻−𝑝𝐾𝑎 + 1)                                                                                                                           (8) 
 
for an acid and, 
 
𝑆 = 𝑆0(10
𝑝𝐾𝑎−𝑝𝐻 + 1)                                                                                                                         (9) 
 
for a base (Avdeef 2001). It can be appreciated from Equations 8 and 9 that the solubility of an 
ionizable compound increases exponentially with the difference between pH and pKa. 
 
 
2.1.3 Lipophilicity 
 
The third thermodynamic equilibrium reviewed in this section is the partition coefficient P 
(often given in the logarithmic form as logP), which describes the partitioning of an 
undissociated or neutral molecule between two immiscible phases. This partitioning is also 
determined by the energy difference between molecules in the two phases, and is expressed by 
the Boltzmann distribution (Eq. 2) as, 
 
𝑋2 = 𝑋1𝑒𝑥𝑝 [
−𝐴(𝛾𝐵𝐶−𝛾𝐴𝐶)
𝑘𝐵𝑇
]                                                                                                            (10) 
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where 𝐴 is the solvent exposed surface area of a molecule or particle (4πr2 for a sphere) and 
𝛾𝐵𝐶  and 𝛾𝐴𝐶  are the interfacial energies between the respective solvent-particle interfaces 
(Israelachvili 1992). 
The partition coefficient is often measured between an organic octanol phase and an 
aqueous phase. The logP can be expressed in a simplified form as the concentration difference 
between these two phases, 
 
𝑙𝑜𝑔𝑃𝑜𝑐𝑡/𝑤 =
[𝐻𝐴𝑜𝑐𝑡]
[𝐻𝐴𝑤]
= 𝑆𝑜𝑐𝑡𝑆𝑤                                                                                                          (11) 
 
where 𝑆𝑜𝑐𝑡 is the equilibrium solubility in octanol and 𝑆𝑊 = 𝑆0 in the case of electrolytes (Jain 
& Yalkowsky 2001). As in the case of the GSE, the interrelationship between lipophilicity and 
solubility is again demonstrated by the fact that the logP can be expressed in terms of solubility 
of a substance in the respective solvent. A higher logP will therefore be generally associated 
with lower aqueous solubility. It can be noted that one of the original aims of logP 
measurements was to find a descriptor that would mimic the partitioning of a molecule 
between an aqueous phase and a cell membrane (Waring 2010). 
For electrolytes, the effect of pKa of the molecule and pH of the solvent have to be taken 
into consideration once more and the logarithm of the distribution coefficient (D) can be 
expressed in a simplified form as,   
 
𝑙𝑜𝑔𝐷𝑜𝑐𝑡/𝑤 = 𝑙𝑜𝑔𝑃 + 𝑙𝑜𝑔 [
1
1+10
𝑝𝐻−𝑝𝐾𝑎
]                                                                                    (12) 
 
for acids and, 
 
𝑙𝑜𝑔𝐷𝑜𝑐𝑡/𝑤 = 𝑙𝑜𝑔𝑃 + 𝑙𝑜𝑔 [
1
1+10
𝑝𝐾𝑎−𝑝𝐻
]                                                                                         (13) 
 
for bases (Scherrer & Howard 1977). The distribution coefficient is always represented with the 
pH at which it was acquired, and describes the ratio of the concentration of the undissociated 
molecule in the organic phase to the concentration of all species in the aqueous phase. For 
neutral compounds logP equals logD, but for electrolytes logP will be higher than logD at pH 
values where the electrolyte dissociates, as the charged species will partition into the aqueous 
phase. 
 
 
2.1.4 Dissolution rate 
 
In contrast to the equilibrium constants presented in the previous sections, the rate of 
dissolution is a kinetic process determined by several equilibria. The dissolution of a solid in a 
liquid involves two steps: overcoming the cohesive forces of the solid phase, by the energetic 
interaction between solute and solvent molecules at the solid-liquid interface; and the 
subsequent diffusion of the dissociated molecules into the bulk solvent. It is thus the difference 
in energy between the intermolecular solid-solid and liquid-liquid interactions and the 
subsequently formed solid-liquid interactions that determine the overall dissolution rate 
(Israelachvili 1992; Yalkowsky & Valvani 1980).  
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The three physical models that are commonly used to describe the dissolution of a pure 
solid substance in a homogeneous solvent are the diffusion layer model (Nernst 1904; Bruner 
& Tolloczko 1901; Noyes & Whitney 1897), the interfacial barrier model (Wurster & Taylor 1965) 
and Dankwerts' surface renewal model (Danckwerts 1951). Of these the diffusion layer model 
has become the most prominently used (Dejmek & Ward 1998; Wurster & Taylor 1965).  
According to the diffusion layer model, a diffusion layer of thickness (h) is formed at 
the solid-liquid interface (Higuchi 1967; Nernst 1904; Noyes & Whitney 1897). Inside this 
diffusion layer a rate limiting concentration gradient is assumed, ranging from saturation 
concentration (S) at the solid-liquid interface (h=0) to the homogenous bulk concentration (𝐶𝑡) 
outside the diffusion layer. The diffusion layer assumption arises from another assumption, 
that the interfacial reaction rate is much faster than the Brownian diffusion or convective rate 
of transport into the solvent (Wurster & Taylor 1965).  
The classical Noyes-Whitney equation was the first to express the diffusion layer theory 
in quantitative terms, 
 
   
𝑑𝐶
𝑑𝑡
= 𝑘(𝑆 − 𝐶𝑡)                                                                                                                               (14)           
 
where 𝑑𝐶/𝑑𝑡 expresses the change in bulk concentration with time (𝑡) and, 
 
𝑘 =
𝐷𝑐𝐴
𝑉ℎ
                                                                                                                                                     (15) 
 
where 𝐷𝑐  is the diffusion coefficient within the layer, 𝑉 is the volume of the solvent and h is the 
thickness of the diffusion layer (Nernst 1904; Bruner & Tolloczko 1901; Noyes & Whitney 1897). 
The similarity of the diffusion rate model with Fick’s laws of diffusion is apparent (Fick 1855). 
The diffusion coefficient for a spherical particle has been theoretically derived with the 
Stokes-Einstein equation (Einstein 1905), however, it can also be approximated from a 
simplified semiempirical version of the equation,  
 
𝐷𝑐 =
2.40×10
−3
𝑀𝑊1/3
                                                                                                                          (16)    
 
(Al-janabi 1990). The diffusion layer thickness, on the other hand, has been estimated to be 
approximately 30 µm, for particles with a radius significantly above 30 µm and to decrease 
proportionally with the particle radius below this threshold (Hintz & Johnson 1989). 
The diffusion layer theory has subsequently been modified to model the dissolution of 
single spherical particles (Niebergall et al. 1963; Higuchi & Hiestand 1963; Hixson & Crowell 
 
𝑀𝑡
𝑥 = 𝑀0
𝑥 − 𝑘𝑥𝑡                                                                                                                                    (17) 
  
where 𝑀𝑡 is the mass of the dissolving particle at time 𝑡, 𝑀0 is the initial mass of the dissolving 
particle and 𝑘𝑥 is a model specific rate constant, three single-particle models can be derived by 
substituting the exponent (x) with ⅓ , ½  or ⅔  (Wang & Flanagan 1999). The cube root 
expression is called the Hixson-Crowell cube root law,  
 
𝐾𝑡 = 𝑀0
1/3
− 𝑀𝑡
1/3
                                                                                                                              (18) 
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and  
𝐾 = 
(
4𝜋𝜌
3
)
1/3
𝐷𝑐𝑆
𝜌ℎ
                                                                                                                        (19) 
 
where 𝜌 is the density of the particle (Wang & Flanagan 1999; Hixson & Crowell 1931). The 
Hixson-Crowell cube root law is the most appropriate of the single-particle expressions to 
model the dissolution of particles larger than the diffusion layer thickness (i.e. 30 µm). It was 
derived assuming a changing surface area under the special case of sink conditions 𝑆 ≪ 𝐶𝑡, i.e. 
in an environment where the dissolved fraction does not affect the dissolution rate and, thus, 
Equation 14 from the perspective of the dissolving particle becomes,   
 
𝑑𝑀
𝑑𝑡
= 𝑘𝐴𝑆                                                                                                                                        (20) 
 
where 𝑑𝑀/𝑑𝑡 expresses the change in mass of the particle with time. The rate of dissolution 
per surface area and time, measured under sink conditions, is called the intrinsic dissolution 
rate (IDR), 
 
𝑑𝑀
𝐴𝑑𝑡
=
𝐷𝑐
ℎ
𝑆                                                                                                                                            (21)           
 
(Serajuddin & Jarowski 1985; Levich 1962). It should be noted that due to possible self-
buffering activity of ionizable compounds, the rate limiting solubility factor in Equations 14 
and 19 to 21, will be the solubility of the dissolving substance at the pH of a saturated solution 
(Serajuddin & Jarowski 1985). 
It can be observed from the preceding section, that solubility and thus lipophilicity and 
charge state are intimately related with the dissolution rate (Eqs. 14, 19 to 21). As stated in the 
beginning of the chapter, one has to bear in mind that the equations presented herein are often 
only approximate and do not remove the need for accurate experimental measurements. This 
becomes especially true under complex physiological conditions, which cannot be accurately 
modeled by simple two phase equilibria. For example, factors such as effects of the formulation, 
excipients, temperature, ionic strength, surface active agents and the mean intestinal transit 
time (MITT) all come into play for drug products during in vitro experiments, and further after 
in vivo administration orally into the gastrointestinal (GI) tract or by other routes (Dressman 
et al. 1998).  
 
 
2.2 Physicochemical parameters in pharmaceutical research 
 
Key physicochemical properties determining the developability and biological activity of 
compounds include pKa, solubility, dissolution rate, lipophilicity, permeation (P), stability, 
MW, polar surface area (PSA), number of hydrogen bond donors (HBD) or acceptors (HBA) 
and the number of rotatable bonds (NROT) (Waring 2010; Alsenz & Kansy 2007; Kerns 2001; 
Lipinski et al. 1997). These substance characteristics have been combined in different ‘rules’ 
and frameworks in order to categorize molecules and describe their lead- or drug-likeness. 
Some examples include Lipinski’s rule of five, the rule of three, lipophilic ligand efficiency 
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(LLE), ligand-efficiency-dependent lipophilicity (LELP), the 3/75 rule, Veber’s criteria and the 
biopharmaceutics classification system (BCS) (specifics are found in Table 1) (Keserü & 
Makara 2009; Hughes et al. 2008; Leeson & Springthorpe 2007; Congreve et al. 2003; Veber 
et al. 2002; Lipinski et al. 1997; Amidon et al. 1995). 
 
Table 1. Lead-/drug-likeness, developability criteria and the biopharmaceutics classification system 
(BCS) 
Rule of five1 HBD <5, HBA <10, MW <500, logP <5 
BCS II 
Low S, 
High P 
BCS I 
High S, 
High P 
Rule of three2 HBD ≤3, HBA≤3, MW <300, logP ≤3 
LLE3 logP/ligand efficiency (0-7.5) 
LELP4 pIC50 (or pKi) – logP (or logD) >5-7 BCS IV 
Low S,  
Low P 
BCS III 
High S, 
Low P 
3/75 rule5 logP <3, PSA >75 Å2, if Cmax <10 µm 
Veber’s criteria6 PSA ≤140 Å2 (or HBD+HBA ≤12), NROT ≤10 
1(Lipinski et al. 1997), 2(Congreve et al. 2003), 3(Leeson & Springthorpe 2007), 4(Keserü & Makara 
2009), 5(Hughes et al. 2008), 6(Veber et al. 2002). H-bond donor (HBD), H-bond acceptor (HBA), 
molecular weight (MW), partition coefficient (P), distribution coefficient (D), half maximal inhibitory 
concentration (IC50), inhibition constant (Ki), polar surface area (PSA), peak serum concentration (Cmax), 
number of rotatable bonds (NROT), solubility (S), permeability (P). 
 
 
The main aim of such characterization is to identify the most promising compounds and 
solid forms that will achieve a therapeutic and non-toxic profile in vivo, by the intended route 
of administration (Alsenz & Kansy 2007; Leeson & Springthorpe 2007; Gardner et al. 2004). 
It is evident that the earlier high quality parameters can be achieved, the faster the decision-
making and, consequently, the whole drug development process will be. Many of the 
aforementioned parameters can be acquired from in silico data, whereas permeation and 
stability measurements require more advanced methods. Solubility, dissolution rate, 
lipophilicity and pKa, which are fundamental throughout pharmaceutical research can, on the 
other hand, be experimentally acquired by relatively simple in vitro techniques.  
Solubility, dissolution rate, pKa and lipophilicity profoundly influence the PK of a 
compound (Figure 1) (Waring 2010; Tong et al. 2009).  These parameters are also 
determinants of pharmacological efficacy, as only a dissolved molecule remaining in solution 
at the site of action will elicit any therapeutic response (Morgan et al. 2012; Gleeson 2008). As 
stated by Curatolo: “An efficacious but nonabsorbed agent is no better than a well-absorbed 
but inefficacious one” (Curatolo 1998). Data of these properties are important input 
parameters for in silico prediction software and are used in the preclinical discovery phase to 
establish quantitative structure activity (QSAR) and quantitative structure property 
relationships (QSPR) (Tong et al. 2009; Alsenz & Kansy 2007; Gardner et al. 2004; Kerns 
2001).  
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Figure 1. Physicochemical properties of substances and impact. Molecular properties determine 
substance properties, which in turn determine the bioavailability, biological activity, efficacy and fate of 
a drug in the development process. Absorption, distribution, metabolism, excretion and toxicity 
(ADMET), ionization constant (pKa), molecular weight (MW), H-bond donor (HBD), H-bond acceptor 
(HBA), number of rotatable bonds (NROT), polar surface area (PSA). 
 
 
With up to 75% of current drug candidates demonstrating low aqueous solubility, the 
importance of solubility assessment as a predictive tool for in vivo drug biological activity is 
increasing (Di et al. 2009). Solubility in various media including aqueous buffers, organic 
solvents, formulation vehicles and simulated or native biological fluids is assessed in order to 
assist in synthesis and solid form optimization, administration route selection, formulation 
strategies for animal toxicology and clinical studies, processability assessment and to indicate 
potential PK liabilities of the compounds (Alsenz & Kansy 2007; Gardner et al. 2004; Kerns 
2001; Merkle & Jen 2002). Dissolution rate is assessed in particular for poorly soluble active 
pharmaceutical ingredients (APIs) of BCS classes II and IV intended for oral administration 
(Tong et al. 2009; Alsenz & Kansy 2007). Especially the dissolution rate and apparent 
solubility can be enhanced through chemical structure, salt and solid form modifications 
(Sugano et al. 2007; Faller & Ertl 2007; Huang & Tong 2004). 
The lipophilicity of a molecule, on the other hand, greatly influences all ADME 
parameters. The most obvious connection is with aqueous solubility, with increased 
lipophilicity resulting in a decrease in aqueous solubility (Waring 2010; Gleeson 2008). High 
lipophilicity is also related to increased metabolism through higher binding affinity with drug-
metabolizing cytochrome P450 enzymes (Gleeson 2008; Lewis & Dickins 2003). Low 
lipophilicity, on the other hand, has been linked to bioavailability issues through an increase 
in renal clearance and decrease in biological membrane, e.g. intestinal or blood-brain barrier, 
permeation (Waring 2010; Gleeson 2008).  The link between lipophilicity and in vitro cellular 
permeability on in vivo absorption has been thoroughly established (Waring 2010; 
Linnankoski et al. 2006; Winiwarter et al. 1998; Lipinski et al. 1997). Furthermore, 
lipophilicity has been found to be a major determinant in the degree of plasma protein and 
tissue binding, as well as the distribution in the body and on a cellular level (Gleeson 2008; 
Valko et al. 2003; Gerweck et al. 1999). Studies have also found a difference between the degree 
of lipophilicity of drugs between target protein classes and therapy areas (Waring et al. 2015; 
Leeson & Springthorpe 2007; Morphy 2006). The charge state of a molecule, determined by 
the pKa, plays a complex role in all of these processes. It is generally acknowledged that a 
molecule will dissolve more readily in the ionized form, while a molecule predominantly 
permeates cellular membranes in the neutral form (Waring 2010). The effect of charge state 
 Review of the literature  
 
11 
 
on other ADME parameters is more intricate and not equally well understood (Gleeson 2008). 
Obviously, all of the aforementioned physicochemical characteristics will continue to affect the 
distribution and accumulation of substances also in the environment after being eliminated 
(Bangkedphol et al. 2009).  
As a consequence of the introduction of HTS and combinatorial chemistry for identifying 
potent hits, the trend in drug development candidates has shifted toward poorer 
physicochemical properties including high lipophilicity and poor aqueous solubility (Alsenz & 
Kansy 2007; Leeson & Springthorpe 2007; Gardner et al. 2004). Such issues of inadequate 
physicochemical properties of candidate molecules can lead to more challenging development 
programs and time-consuming iterations in the R&D process (Waring et al. 2015; Leeson & 
Springthorpe 2007; Kola & Landis 2004; Gardner et al. 2004). However, concurrently the 
attrition of NMEs directly caused by inadequate PK and bioavailability issues has decreased 
significantly during the last two decades, currently accounting for some 10% of all attrition 
(Waring et al. 2015; Kola & Landis 2004).  
The two major causes of attrition today are inadequate safety and efficacy (Waring et al. 
2015; Cook et al. 2014; Kola & Landis 2004). The indirect effect of poor physicochemical 
properties of compounds behind these main causes could, however, be substantial, and the 
importance of thorough physicochemical characterization has lately, once again, been brought 
into focus (Waring et al. 2015; Morgan et al. 2012; Gleeson 2008; Leeson & Springthorpe 2007; 
Di & Kerns 2006).  
While solubility is mainly assessed in the framework of PK it also plays an intricate role 
in many processes including biological assays (Di & Kerns 2006; Gardner et al. 2004). This is 
because insufficient solubilization and potential precipitation and aggregation of a compound 
under storage and biological assay conditions can lead to erroneous estimations of compound 
activity (Di & Kerns 2006). For example the reduced concentration of insoluble compounds in 
a HTS assay, led to a hit rate of 4%, while compounds of higher solubility showed a hit rate of 
32% (Popa-Burke et al. 2004). As poor aqueous solubility of lead molecules has become a 
major issue, up to 30% of lead compounds could have their activity wrongly estimated in 
ADME and toxicology (ADMET) assays due to an inability to reach sufficient concentrations 
(Di et al. 2009; Lipinski 2001). The importance of knowing the solubility of development 
compounds in different environments is thus highlighted (Di & Kerns 2006). Furthermore, co-
solvents such as dimethyl sulfoxide (DMSO) can interfere with enzyme and cell assays, leading 
to discrepancies in the data (Di & Kerns 2006). It is obvious that false data will lead to 
inaccurate QSAR modeling, problems with false or missed leads and unnecessary iterations 
downstream in the R&D process (Di & Kerns 2006; Gardner et al. 2004). It would therefore 
be important to screen solubility under assay conditions before initiating biological activity 
screens (Alsenz & Kansy 2007). Going further, an inability to achieve meaningful plasma levels 
in preclinical animal studies, due to poor solubility and insufficient dissolution, can mask 
underlying toxicity and metabolic issues that will appear only at a later, more costly stage in 
the development process (Gardner et al. 2004).   
High lipophilicity is, on the other hand, strongly correlated with increased risk for 
pharmacological promiscuity, i.e. the binding to multiple targets, one of the causes of 
toxicology attrition (Waring et al. 2015; Leeson & Springthorpe 2007). Lipophilicity is also 
strongly connected with two other causes of specific toxicity common for drugs: the binding 
affinity to the cardiac hERG potassium channel and drug induced phospholipidosis (Waring & 
Johnstone 2007; Tomizawa et al. 2006; Ploemen et al. 2004). Such ‘off-target’ toxicological 
events have been found to contribute to up to 75% of preclinical safety attrition (Cook et al. 
2014). A narrow range of logD between 1 and 3 has been identified as the optimal range to 
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avoid developability and toxicology issues while maintaining sufficient potency (Waring 2010). 
For example compounds with a calculated logP above 3 were found to be 2.5 times more toxic 
than compounds within the optimal range in in vivo animal studies (Hughes et al. 2008).  
The relationship between increased lipophilicity and increased risk of attrition in clinical 
safety studies has also been demonstrated (Waring et al. 2015). A statistically significant 
decrease in calculated logP and logD7.4 values has been observed for drug candidates 
progressing into later stage clinical development phases, with launched drugs having the 
lowest lipophilicities (Waring et al. 2015; Wenlock et al. 2003). This suggests a direct effect of 
higher lipophilicity on compound attrition in both discovery and development. Efficacy issues 
can, on the other hand, arise due to limitations in the dose or inability to achieve sufficient 
exposure in the target tissue (Cook et al. 2014). As previously discussed, these issues can be 
related to physicochemical characteristics of the compounds, and account for some 30% of 
efficacy related attrition. 
As has been discussed, the direct and indirect effects of drug physicochemical properties 
are paramount during the whole R&D process. There is evidence that both poor solubility and 
high lipophilicity increases the risk of developability and safety issues, as well as compound 
attrition (Alsenz & Kansy 2007; Leeson & Springthorpe 2007). Recently, a shift toward a more 
holistic approach in compound selection and optimization has been indicated, with an aim to 
achieve increased potency while simultaneously maintaining optimal physicochemical 
characteristics of the drugs (Leeson & Springthorpe 2007; Gardner et al. 2004). The incentive 
surely exists as only a 5% improvement in attrition would result in a twofold increase in the 
output of new drugs (Leeson & Springthorpe 2007). In order to achieve this, high quality 
procedures and technologies are required, from the earliest stages of the R&D process. 
 
 
2.3 Physicochemical characterization methods 
 
It has been estimated that up to 1024 different drug compounds could be synthesized by modern 
combinatorial chemistry (Ertl 2003). The vast amount of molecules being screened by HTS for 
potency and the practically infinite chemical space represented by these possible drug 
molecules, poses a real challenge for analytical methods in preclinical R&D. Another issue for 
early physicochemical property assessment is the low amounts (less than a few milligrams) of 
available compound for physical in vitro screening at this stage (Lipinski et al. 1997; Sugano 
et al. 2007; Kerns 2001). At later stages in the development process, where larger batches of 
higher purity of the most promising candidates are synthesized, the need for rapid 
characterization methods persists as the number of screened solvents increases markedly 
(Alsenz & Kansy 2007). In light of this, a set of optimal requirements for high throughput 
physicochemical profiling methods has been proposed (Gardner et al. 2004; Kerns 2001): 
 
- Throughput of >50 compounds/instrument/day; 
- Low total substance consumption (mg);  
- Non-specific methods for coverage of wide chemical space; 
- Quality information relevant for decision-making; 
- Automation of sample preparation, measurement and analysis.  
 
In summary, the challenge lies in decreasing resource and time consumption, while 
simultaneously maintaining the quality of the aquired data. 
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2.3.1 In silico methods  
 
Due to the lack of experimental methods capable of accommodating the requirements for 
throughput and low materials consumption, computational methods are used in early 
discovery (Tetko et al. 2009; Gardner et al. 2004). However, these in silico methods are also 
challenged by the vast dimensionality of the possible chemical space of drug molecules (Tetko 
et al. 2009). 
In silico models are inherently limited to their applicability domain, i.e. to the chemical 
space of the training set used to validate a method (Tetko et al. 2009; Mannhold et al. 2009; 
Faller & Ertl 2007). Despite considerable efforts to develop accurate in silico methods for 
solubility, lipophilicity and pKa prediction, the lowest achievable root mean square errors 
(RMSE) of predictions within the applicability domains generally remain around 0.8 log units 
(Balogh et al. 2012; Tetko et al. 2009; Mannhold et al. 2009; Jorgensen & Duffy 2002). 
Outside this domain the prediction errors can be as high as 1 to 3 log units and a general 
arithmetic average model, where the average value of the training set is attributed to all 
molecules, often succeeds better than an actual prediction.  
Moreover, in silico models are validated by their comparison with experimental values. 
Consequently, one of the reasons for the poor predictivity, even within the applicability 
domains of the models, has been attributed to the lack of high quality homogeneous datasets 
of experimental values, commonly referred to as ‘garbage in garbage out’ (Di et al. 2012; Tetko 
et al. 2009; Faller & Ertl 2007; Linnankoski et al. 2006). Furthermore, the experimental input 
parameters used in validation studies have to be acquired under a potentially large range of 
relevant chemical conditions reflecting the model environment (Bangkedphol et al. 2009; 
Sugano et al. 2007). It is therefore generally believed that the accessibility of accurate high-
quality experimental datasets would improve prediction accuracy by minimizing the 
systematic errors introduced through poor input parameters (Tetko et al. 2009). 
As first introduced by Hansch (Hansch et al. 1968), most in silico methods for solubility 
prediction, e.g. the GSE (Eq. 6), are based on the relationship between logP and S0. Due to the 
lack of high-quality experimental datasets, calculated logP values in combination with a 
variation of molecular descriptors, such as the PSA, are generally used (Faller & Ertl 2007). It 
is evident that the predictive power of solubility models will be limited by the inherent error of 
the underlying calculated logP values, in addition to the errors of the actual solubility model. 
In the case of solubility, lattice energies and crystal packing calculations, in particular, require 
expensive computations and are difficult to predict (Faller & Ertl 2007). Furthermore, most in 
silico models are only applicable for predicting logP and water solubility of neutral and 
undissociated molecules, and are often confined to the parent moiety (i.e. not salts or solvates) 
(Gardner et al. 2004). Some methods have been developed for solubility in DMSO, surfactants 
and cosolvent solutions, but most models do not consider the complex composition of GI fluids 
(Alsenz & Kansy 2007; Gardner et al. 2004). In case of ionizable molecules the accuracy of the 
logD and solubility predictions will further depend on the calculated pKa value (see Eqs. 8, 9, 
12 and 13). These uncertainties need to be taken into account in decision-making as well as in 
the analysis of, for instance, lipophilicity and solubility dependent attrition (Waring 2010).  
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2.3.2 In vitro methods 
 
It is evident from the foregoing section, that in silico predictions have not diminished the need 
for high-quality and HTE methods in pharmaceutical research. In this section some of the most 
used miniaturized experimental methods will be reviewed.  
 
 
2.3.2.1 Dissolution rate 
 
The kinetic nature of dissolution could reflect in vivo events in more detail than solubility, as 
dissolution rate data incorporates the initial wetting stage, the impact of diffusion as well as 
the effect of solid state properties (Zakeri-Milani et al. 2009; Yu et al. 2004). Thus, earlier 
acquisition of dissolution rate data would provide high quality input parameters for early stage 
ADMET models (Alsenz & Kansy 2007). Especially the intrinsic dissolution rate could be 
suitable for high-throughput screening applications, since data from only the first 10% of the 
dissolution curve is usually required for determination (USP 2015). Moreover, due to the 
higher in vivo relevance of dissolution rate data, it has been proposed that IDR, rather than 
solubility, should be the basis of the biopharmaceutical classification of drugs (Table 1) (Yu et 
al. 2004).  
Despite these apparent advantages, small scale dissolution methods are scarce and 
miniaturization is often based on the well-known compendial apparatus (USP 2015; Klein & 
Shah 2008). The method most often used as a comparison in these measurements is the disc-
IDR (DIDR). One miniaturized version of the DIDR apparatus, the Mini-IDR method, has 
shown good correlation with DIDR data, and the substance consumption in this method has 
been reduced to as little as 5 mg per experiment (Avdeef 2008).  
Non-traditional methods have also been presented. One variation is a flow-through setup 
using detection by UV imaging and requiring sample amounts of 3-10 mg per experiment 
(Østergaard et al. 2014; Hulse et al. 2012). Another, the powder-IDR (PIDR) method 
introduced by Tsinman and coworkers (2009), has produced comparable data with the 
standard DIDR method, using powder samples as small as 60 µg and in situ fiber-optic UV 
analysis. The disadvantage of powder based approaches lies in the lack of understanding and 
the difficulty of modeling multiparticle systems, leading to rough estimations (Hulse et al. 2012; 
Avdeef et al. 2009; Wang & Flanagan 1999; Mosharraf & Nyström 1995). Small particles have 
larger surface energies, due to the increased surface curvature, increasing the probability of 
particle aggregation and agglomeration (Yu 1999; Wang & Flanagan 1999). The dissolution 
rate of multiparticle systems is therefore an expression of the dissolution from the mean 
effective surface area, determined by the particle size distribution and the extent of aggregation 
and agglomeration in the system (de Villiers 1996). The difficulty is further increased by the 
dynamic change of these factors during the dissolution process. 
The drawback of the Mini-IDR and flow cell methods is the relatively high substance 
consumption and the need for sample preparation, often into a compact of known surface area 
(Hulse et al. 2012; Avdeef 2008). In addition, all the methods have relatively low throughput 
and are based on specific UV detection, thus increasing the use of substance through detection 
range scanning and calibration. 
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2.3.2.2 Solubility, lipophilicity and pKa 
 
‘Gold standard’ shake-flask method  
 
The ‘gold standard’ method for solubility and lipophilicity assessment is the classical 
thermodynamic shake-flask method (OECD 2016a; OECD 2016b ; Kerns 2001; Danielsson & 
Zhang 1996; Dittert et al. 1964). For thermodynamic solubility to be determined, an excess 
amount of solid is brought in contact with the solvent, and the equilibrium concentration is 
determined after long incubation times, usually in the range of several hours to days (Alsenz & 
Kansy 2007; Sugano et al. 2007; Lipinski et al. 1997). For lipophilicity measurements, a similar 
shaking and phase separation timeframe is required (Danielsson & Zhang 1996). The amounts 
required per experiment are generally in the mg and g range and quantitation requires 
substance specific chemical analysis, after separation of solid from the liquid or of the two 
liquid phases. Consequently, accurate determination of equilibrium solubility and lipophilicity 
by traditional means is both time and substance consuming.  
While thermodynamic solubility is often regarded as the ‘true’ solubility, the measured 
values are not absolute and depend on both compound properties and experimental factors 
(Alsenz & Kansy 2007). Such factors can be related to weighing, adsorption and absorption to 
materials during liquid sample handling, such as filtration, centrifugation and pipetting and 
further to analytical discrepancies. In fact, the range of uncertainty of thermodynamic 
solubility values reported in literature has been shown to be in the range of 0.6 log units 
(Jorgensen & Duffy 2002; Katritzky et al. 1998).  
Miniaturized versions of the shake-flask method, some 96-well plate based, have been 
developed for both solubility and lipophilicity studies (Heikkilä et al. 2011; Glomme et al. 2005; 
Bergström et al. 2004; Kerns 2001). While the substance consumption in these methods has 
been substantially decreased to around 1 mg, the time scale of the measurements is still 
comparable to that of the shake-flask method, i.e. several hours and usually up to 24 h. High-
throughput applicability of thermodynamic solubility measurements is therefore not yet 
possible.  
 
Potentiometric methods   
  
For pKa measurement, the classical method is potentiometric acid-base titration (Comer 2003; 
Kerns 2001). In this method, the pH is measured continuously during acid or base titrant 
addition and the difference spectrum between a pure water blank run and a run with the 
dissolved compound gives the pKa (Slater et al. 1994). As the compound has to be dissolved in 
pKa measurements, it is often challenging to acquire quantifiable concentrations for poorly 
soluble compounds (Takács-Novák et al. 1997). In such cases organic cosolvents can be used, 
and the results from different ratios of the organic and aqueous phases extrapolated to pure 
aqueous phase, with good correlation. One automated aqueous titration usually requires 10-
30 min, but with cosolvent systems the amount of runs will obviously be manyfold (Slater et 
al. 1994).  
Potentiometric analysis can also be used for logP measurement of ionizable molecules 
(Slater et al. 1994). In this case, logP is calculated from the shift in pKa, called apparent pKa, 
caused by partitioning of the neutral species into the octanol phase. The time required for such 
runs is generally 20-60 min. Further, potentiometry can be used to determine aqueous 
solubilities of ionizable molecules (Avdeef 1998). During potentiometric solubility 
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measurement, the titration starts from a pH at which the molecule is fully ionized and dissolved 
(Avdeef 1998). As the titration progresses, precipitation occurs in the range of the pKa of the 
molecule. Analogous to the case of logP measurement, an apparent pKa shift occurs due to 
precipitation of the poorly soluble neutral species. Solubility is then calculated based on the 
difference between the apparent pKa and the known true pKa of the substance. The method has 
been shown to produce comparable results with the ‘golden standard’ shake-flask method 
(Glomme et al. 2005; Avdeef et al. 2000). Approximately 100 µg of substance is required per 
run and produces a full pH-solubility profile (Glomme et al. 2005; Avdeef & Berger 2001). The 
time required for a potentiometric titration depends on the solubility of the compound as well 
as the solvents used. One run generally requires 3-36 h and a throughput of three poorly 
soluble substances per week has been estimated (Stuart & Box 2005; Glomme et al. 2005).  
A simplified version of the potentiometric method called ‘chasing equilibrium’ has been 
introduced for more rapid assessment of intrinsic solubility of ionizable compounds (Stuart & 
Box 2005). In this procedure, the intrinsic solubility equilibrium is actively sought, by addition 
of acid or base titrant, to alternately dissolve and precipitate the sample. Monitoring the 
change in pH during the process enables the determination of the pH at which the rates of 
precipitation and dissolution are equal. Intrinsic solubility measurement using this method 
requires typically between 20-80 min and the lower limit for the required amount of sample is 
around 2-5 mg, with an average of around 60 mg per measurement.  
A prerequisite for potentiometric determination of solubility and lipophilicity is an 
accurate value for the pKa(s) of the molecule, with the estimation error between e.g. pKa and 
logS0 being directly proportional. While the potentiometric solubility method produces a full 
pH-solubility profile, from as little as 100 µg of sample, the throughput of the method brings 
no real advantage in time compared to the shake-flask method. The ‘chasing equilibrium’ 
method, on the other hand is substantially faster, but requires comparably large amounts of 
substance. It is apparent from the timescales of the potentiometric pKa, lipophilicity and 
solubility measurements that high-throughput applicability of the method is not yet possible. 
However, the greatest disadvantage of potentiometric solubility measurement is that it is 
limited to ionizable molecules.  
 
Chromatographic and gradient analysis methods 
 
Reversed phase high-performance liquid chromatography (HPLC), capillary electrophoresis 
(CE) and spectral gradient analysis (SGA) have also been applied to determine pKa and 
lipophilicity of compounds (Cabot et al. 2015; Box et al. 2003; Lombardo et al. 2000; Poole et 
al. 2000; Valkó 1997). These methods require very small liquid sample amounts (µL range) 
and are applicable in high-throughput studies, with quantitation usually based on UV or mass 
spectrometry (MS). In reversed phase HPLC and CE, the movement of a molecule through a 
column depends on the partitioning between a stationary organic phase and a moving aqueous 
phase, or on the different electrophoretic mobility of neutral and ionized species (Cabot et al. 
2015; Lombardo et al. 2000; Poole et al. 2000; Valkó 1997). SGA, on the other hand, is based 
on injecting samples into a linearly changing pH gradient flow, and detecting the change in UV 
absorbance of a chromophore near to the ionization center of the dissociating molecule (Box 
et al. 2003).  
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Kinetic solubility 
 
For high-throughput solubility measurement, the currently most used method in preclinical 
drug discovery is the kinetic solubility method (Alsenz & Kansy 2007). Kinetic solubility is 
determined starting from dissolved compound, usually DMSO stock solutions, as the time 
point preceding precipitation in a dilution series into aqueous buffer (Alsenz & Kansy 2007; 
Lipinski et al. 1997; Bevan & Lloyd 2000). In the turbidimetric method, an amount of DMSO 
stock solution of known concentration is added at the rate of 1 mL/min into a cuvette 
containing pH 7 phosphate buffer (Lipinski et al. 1997). Precipitates are detected in a UV 
spectrophotometer from the absorbance increase of the turbid solution. The nephelometric 
method, on the other hand, uses serial dilution of the stock solution of known concentration 
into a 96-well plate (Bevan & Lloyd 2000). The plate is scanned by a laser nephelometer and 
the scattered light at a right angle is measured. 
Kinetic solubility measurement is the only solubility method currently achieving high-
throughput, with a capability of analyzing 50-300 samples per day (Glomme et al. 2005). 
Another advantage of the method is the use of DMSO stock solutions, which are readily 
available from HTS assays. Moreover, methods based on light scattering are non-specific and 
applicable to all substances and transparent solvents as such.  
However, kinetic solubility values have been shown to be poor predictors of equilibrium 
solubility, with estimation errors up to 1.7 log units (Lipinski et al. 1997; Stuart & Box 2005). 
The uncertainty arises from several sources. The presence of DMSO in the solution, in addition 
to the short incubation times, often leads to supersaturation by solubilization and precipitation 
of an unstable or a metastable form in accordance with the ‘Ostwald rule of stages’ (Sugano et 
al. 2007; Alsenz & Kansy 2007; Kerns 2001; Ostwald 1897). Furthermore, the act of 
predissolving in DMSO masks the influence of crystal lattice energies and polymorphic forms 
on solubility, and consequently, the data is not applicable as an input parameter for QSPR 
assessment (Huang & Tong 2004; Lipinski et al. 1997). As the measurement error is in the 
range of in silico prediction uncertainty (as previously reviewed), the question can be raised if 
such experimental values provide any additional value to the research scientist.  
 
Based on this review of current state of the art methods for physicochemical analysis, it is 
evident that no one method is capable of accurate assessing all of solubility, lipophilicity and 
pKa. For solubility measurement in particular, there appears to be a discrepancy between 
throughput, substance consumption and accuracy. High-throughput invariably leads to higher 
substance consumption, or conversely a decrease in accuracy. High accuracy on the other hand 
requires slow measurements or higher amounts of substance. In order to achieve a unity 
between these aspects, novel approaches are needed. 
 
 
2.4 Microscopy and single-particle analysis 
 
The development, implementation and validation of an analytical method can often be the 
most time-consuming step of an experimental process (Glomme et al. 2005). One weakness of 
commonly used chemical analysis techniques is the extensive sample preparation, which 
includes both sample and calibrant preparation (Paakkunainen et al. 2009; Alsenz & Kansy 
2007). The total measurement error of a method is, obviously, determined by the inherent 
error in every step of the procedure (Paakkunainen et al. 2009; Faller & Ertl 2007). This is 
especially true for miniaturized high-throughput measurements, where the relative error is 
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increased with decrease in sample size. While UV spectrophotometry is the most widely 
available chemical analytisis technique, the analysis of small and dilute samples often requires 
more sophisticated analytical methods, such as HPLC-MS or tandem mass spectrometry 
(HPLC-MS/MS) (Korfmacher 2005; Tiller et al. 2003). These methods are also the most used 
techniques for high-throughput quantitative analysis, with automated and optimized HPLC-
MS methods achieving sample analysis times as low as 15 s per sample (Saunders 2004). The 
drawback of such advanced methods is, however, that the apparatus is expensive and costly to 
operate. 
Due to the wide range of chemical space covered by drug molecules, different, often 
substance and solvent specific, analytical methods are required (Tiller et al. 2003; Sacher et al. 
2001). For example, in an attempt to analyze 60 different pharmaceutical compounds with a 
minimum amount of either gas chromatography-MS or HPLC-MS/MS methods, 6 different 
methods were needed (Sacher et al. 2001). More non-specific methods such as potentiometry 
suffer from other limitations, such as being confined to ionizable molecules (as reviewed in 
section 2.3.2.2.). Particle based analysis such as turbidimetry, on the other hand, is truly non-
specific, as it does not depend on the chemical properties of the studied molecules or solvents. 
Such methods could therefore be opportune for high-throughput requirements.  
 
 
2.4.1 Image-based analysis 
 
Particle characterization methods are widely used in pharmaceutical sciences where the 
accurate shape and size analysis is regarded as the ‘gold standard’ in understanding powders 
and particulate systems (Gamble et al. 2015; Allen 1990). Optical microscopy has been a widely 
used technique in such morphological characterization of particles, but only recently have 
advances in digital imaging, computing and image analysis software enabled the use of optical 
microscopy in automated real-time analysis (Gamble et al. 2015; Burggraeve et al. 2011; 
Almeida-Prieto et al. 2006; Allen 1990).  
Optical microscopy is generally used to study particles in the size range of 3 μm – 150 
μm, i.e. the typical size range of pharmaceutical powders (Gamble et al. 2015; Allen 1990). The 
traditional minimum resolution of optical microscopy is 0.8 μm, however, the rapid 
advancement of digital image processing has already enabled the surpassing of this limit, with 
modern advanced optical techniques achieving spatial resolutions below 100 nm (Cotte et al. 
2013).  Another limitation of traditional optical microscopy is the limited depth of field. For 
example, when moving from a magnification of 100x to 1000x, the depth of field changes from 
around 10 mm to approximately 0.5 mm (Allen 1990). 
The typical method to capture and process data acquired by microscopy, is imaging and 
image analysis. Light from the analyzed object is detected by an image sensor, usually a charge 
coupled device (CCD) or a complementary metal–oxide–semiconductor (CMOS) sensor, 
which then translates the data into digital micrographs. A digital image is composed of multiple 
squares called picture elements or pixels. The spatial resolution of an image is thus determined 
by the amount of pixels per image area and it has been shown that around 50 pixels are needed 
for a reliable assessment of particle shape (Gamble et al. 2015; Kröner & Doménech Carbó 
2013).  
In order to facilitate analysis, color micrographs [red, green and blue (RGB) channels] 
are usually converted into grayscale (monochrome) (Allen 1990). The pixels of monochrome 
images are represented by a numerical value between 0 and 255. This value determines the 
grayscale shade, with 0 representing a black pixel and 255 a white pixel, depending on the 
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brightness and hue of the individual pixels of the original RGB micrograph. The micrograph is 
then usually further processed, by e.g. removing noise and background, improving contrast 
and defining a region of interest (ROI) for further analysis. A multitude of more or less 
advanced processing algorithms exist for both open source and commercial platforms. The 
processing usually ends in defining a grayscale threshold value, based on which all pixels with 
numerical values below the threshold get the value 0 (black) and all pixels with numerical 
values above the threshold get the value 255 (white). Through this thresholding process, a 
black and white binary image is produced, which can be further optimized for analysis, through 
e.g. smoothing, filling holes, defining edges and boundaries and segmenting regions. Image 
analysis can then be performed and object characteristics extracted. 
In order to enable accurate 3D characterization of particle morphology, the particle 
generally has to be imaged from two or more defined or random angles (Frank et al. 1996; 
Podczeck 1995). As imaging is usually performed from only one direction, the orientation of 
the analyzed object determines the captured two-dimensional projection. For symmetrical 
objects such as spheres, that show the same two-dimensional projection in all directions, this 
is not an issue. 3D characteristics of non-spherical particles (i.e. volume and surface area), 
however, are usually based on equivalent sphere approximations. Therefore, a shape factor has 
to be applied to correct for the divergence from the ideal spherical shape. Several shape-factors, 
based on different ratios of the measured particles, have been developed through the years 
(Blott & Pye 2007). However, the assignment of shape factors to particle morphologies is non-
trivial, and remains ambiguous and one of the most difficult particle characteristics to quantify 
(Blott & Pye 2007; Podczeck 1997). 
 
 
2.4.2 Single-particle analysis 
 
Despite these challenges, image-based microscopy could have great potential as an analytical 
method. The advantages of image analysis over other methods are as follows: non-specificity, 
straightforward automation, potential for very rapid data acquisition and real-time analysis, 
reduction of sampling steps and the avoidance of liquid sample handling, reduction of operator 
contact with potentially hazardous substances, as well as the possibility for reanalysis and 
visual inspection of possible causes of deviation in the acquired data.  
Indeed, image-based microscopy has rapidly been gaining ground in biosciences, where 
it is used in e.g. high content analysis (HCA) of single cells, allowing the mining of large 
amounts of cell specific characteristics in a fast, robust and cost-effective manner (Marx 2012; 
Bakal et al. 2007). Further, the synergistic fusion of photonics and fluidics in smart diagnostic 
systems, so called optofluidic systems, has provided promising new applications for small-
scale life science analytics (Schmidt & Hawkins 2011; Fan & White 2011). For example, optical 
and hydrodynamic single-cell manipulation and trapping has been widely used in 
miniaturization of biomedical studies (Nilsson et al. 2009). 
One of the early single-particle studies in the pharmaceutical field was on the dissolution 
rate kinetics of individual compressed spherical tablets of benzoic acid (Parrott et al. 1955). 
While still rare, some single-particle and single-crystal studies have been published in recent 
years (Börjesson et al. 2013; Østergaard et al. 2011; Marabi et al. 2008; Prasad et al. 2002; 
Raghavan et al. 2002). By studying single particles, the cohesive interactions between particles 
can be ignored and the particle shape and size can be assessed. The single-particle approach 
thus minimizes the assumptions regarding factors influencing the dissolution rate. While, 
according to Aristotle: ”the whole is greater than the sum of its parts”, it can nevertheless be 
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argued that the whole is determined by its individual parts. This is also the case with powders 
and powder dissolution, where the primary particles composing the bulk are the main 
determinants of the overall bulk properties (de Villiers 1996). Single-particle analysis by 
image-based microscopy could therefore provide a promising novel approach to 
pharmaceutical material property characterization and thus demands further investigation.  
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3 Aims of the study 
 
The aim of this thesis was to investigate the applicability of image-based microscopy of single-
particles for physicochemical characterization of materials. In addition, a second aim was to 
develop a non-specific method and miniaturized devices capable of accurate, small-scale and 
rapid characterization and profiling of physicochemical properties of matter. 
 
More specifically, the objectives of this dissertation were to: 
 
     
 investigate and verify the applicability of image-based microscopy as an analytical 
technique for dissolution rate measurement from single-particles (I); 
 
 develop a non-contact single-particle trapping device and extend the image-based 
analysis method to measure the IDR from individual freely rotating microscale 
particles (III); 
 
 extend the image-based single-particle method for rapid miniaturized measurement of 
solubility (II);  
 
 further miniaturize the single-particle method and device, in order to enable analysis 
of individual powder crystals, and to extend the method to lipophilicity and pKa 
measurement (IV). 
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4 Experimental 
 
 
4.1 Materials 
 
 
4.1.1 Solutes 
 
A total of 19 model compounds: acetylsalicylic acid (ASA) (Orion Pharma, Espoo, Finland), 
bioactive glass S53P4 (BonAlive Biomaterials Ltd, Turku, Finland), celecoxib (Kemprotec, 
Carnforth, UK), citric acid monohydrate (Mallinckrodt Baker B.V., Deventer, Holland), 
dicalciumphosphate 2-hydrate (Chemische Fabrik Budenheim KG, Budenheim, Germany), 
furosemide (Orion Pharma, Espoo, Finland/TCI Europe, Zwijndrecht, Belgium), 
hydrochlorothiazide (Alfa Aesar, Lancashire, UK), hydrocortisone (Fagron GmbH, Barsbüttel, 
Germany), ibuprofen (Orion Pharma, Espoo, Finland), indomethacin (Hawkins, MN, USA), 
human recombinant insulin (SAFC Pharma, MO, USA), itraconazole (Orion Pharma, Espoo, 
Finland), ketoprofen (Orion Pharma, Espoo, Finland), naproxen (Orion Pharma, Espoo, 
Finland/ICN Biomedicals Inc., OH, USA), paracetamol (PCM) (Oriola, Espoo, 
Finland/Hawkins, MN, USA), phenytoin (Orion Pharma, Espoo, Finland), probenecid (Sigma-
Aldrich Chemie Gmbh, Steinheim, Germany), theophylline (TP) anhydrate (BASF, 
Ludwigshafen, Germany) and sodium chloride (Riedel-de Haën GmbH, Seelze, Germany) were 
used in the studies. The compounds were used without further purification and chosen to 
represent a maximum variability in solubility and chemical properties. The solubility range 
covered is above 9 log units, ranging from very soluble to practically insoluble.  
 
 
4.1.2 Solvents 
 
Distilled water, ultrapure deionized (MilliQ) water, ethanol (Altia, Rajamäki, Finland), octanol 
(YA Kemia, Helsinki, Finland), phosphate buffer solutions (pH 2.0, 3.0, 4.5, 5.8, 6.8, 8.0) and 
buffer solution (pH 9.0) prepared according to the European Pharmacopoeia 8.8 chapter 4.1.3. 
(Ph.Eur. 2015), phosphate-buffered saline (PBS) solution (Sigma-Aldrich, pH 7.4), as well as 
fed state simulated intestinal fluid (FeSSIF), fasted state simulated intestinal fluid (FaSSIF) 
and fasted state simulated gastric fluid (FaSSGF), prepared according to the manufacturers’ 
instructions, were used as solvents. 
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4.2 Methods 
 
 
4.2.1 Single-particle devices 
 
 
4.2.1.1 Semi-static setup (setup 1) (I) 
 
The semi-static dissolution of individual pellets was performed at ambient temperature (23 ± 
0.5 °C) in 24-well plate wells containing 3 mL of degassed distilled water. In order to achieve 
a homogenous sample for UV spectrophotometric analysis, the well plate was shaken by 
turning three times, with a frequency of 1 turn/s, before sampling. This was performed 
approximately 30 s before sample collection, which allowed a suitable time-frame for the 
particle to settle at the bottom of the well, and for repositioning of the well plate, in order to 
allow simultaneous particle imaging. Between sampling-points the well plate was kept 
undisturbed.  
Dissolution rate measurements of each substance were performed in triplicate, with 
dissolution times for the studied substances ranging between one and a few hours. Depending 
on the initial weight of the particle, sampling points were at 2, 5 and 10 min, and after this at 
intervals of 5 or 10 min. When approaching the end of a measurement in which 10 min intervals 
were used, the sampling rate was again shifted to every 5 min, increasing the frequency of data 
points. A measurement was continued until the particle size had decreased, so that a pellet no 
longer could be found when repositioning the well plate.  
 
 
4.2.1.2 Hydrodynamic vortex particle trap (setup 2) (II-III) 
 
Two issues had to be overcome in order to allow continuous imaging of particles under 
continuous flow conditions. First, the particle had to be positioned and remain in a confined 
area that would allow imaging using a stationary camera and a fixed magnification; second, 
the time consuming step of manual affixation by either gluing or clamping, which has generally 
been used to achieve particle positioning, was to be avoided (Østergaard et al. 2011; Marabi et 
al. 2008; Prasad et al. 2002; Raghavan et al. 2002). Apart from being time-consuming, 
particle fixing is likely to alter the surface morphology, intra-particle lattice energies and, thus, 
the dissolution kinetics of the particles. These challenges were met by design of a flow-through 
dissolution vessel incorporating a hydrodynamic particle trap (Fig. 2). The trapping mode of 
the dissolution cell was achieved by two tangential counter-flow solvent inlets. This resulted in 
a centrally positioned particle trapping vortex, allowing rapid non-contact particle focusing of 
the individual pellets and, consequently, continuous monitoring by optical microscopy.  
Moreover, the rotational freedom of a particle in the vortex removes another common 
problem in particle size analysis, i.e. the settling of particles in a preferential orientation, 
denying the possibility of a 3D estimation of the particle size from one detection angle, an issue 
also present when studying fixed particles (Allen 1990). In this setup, where particles are 
allowed to rotate randomly within the particle trapping zone, an averaged 3D-shape and -size 
characterization is possible by the use of one image sensor and one detection angle only.  
During a measurement at ambient temperature (22±1 °C), 20 mL of degassed distilled 
water, sufficient to maintain sink conditions for all substances during the dissolution process, 
was pumped by a peristaltic pump (Watson-Marlow 503U, Smith & Nephew, Falmouth, 
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Cornwall, England) in a closed loop with a constant flow rate of 10 ±0.05 mL/min through the 
dissolution cell. The solvent was kept in a closed vial under constant stirring. Still images of a 
dissolving freely rotating particle were acquired with a frame rate of 2-60 frames/minute, 
using stroboscopic illumination of the particle. All measurements were done in triplicate. 
 
 
Figure 2. Schematic of the hydrodynamic vortex trap (not to scale). Degassed distilled water (1) 
(22±1 °C) was pumped (2) in a closed loop with a constant flow rate of 10 ± 0.05 mL/min through the 
dissolution cell (3), back to the vial (1). Still images of the dissolving rotating particle (4) were acquired 
through a magnifying lens (5) by a CMOS image sensor (6) with a frame rate of 2-60 frames/minute, 
using stroboscopic illumination (7) of the particle. Copyright © (2015) American Chemical Society, 
modified with permission from publication (II). 
 
 
4.2.1.3 Membrane immobilization flow-through device (setup 3) (IV) 
 
In order to allow the analysis of individual powder grains, a third flow-through device setup 
was developed (Fig. 3). The setup comprises a reaction chamber in which individual powder 
grains are immobilized on a membrane by the solvent flow across the particles and through 
the membrane. The flow-through device consisted of two resistant metal plates. The lower 
plate hosted a 1 mm outlet channel and the top plate hosted the inlet channel as well as a glass 
window to facilitate imaging. A 0.2 µm polycarbonate membrane filter (Whatman Nuclepore 
Track-Etched Membrane) was placed on the bottom plate and the particles to be analyzed were 
placed on top of this filter. The reaction chamber was tightly sealed before the start of a 
measurement.  
During a measurement, solvents were degassed and pumped (Agilent 1260 Infinity 
Quaternary Pump) through the flow-chamber in an open configuration, with a constant flow 
rate of 1 mL/min. The temperature was adjusted by flowing the solvent through a 
thermostatted column compartment (Agilent 1200 Series). Imaging was performed through 
the transparent top part of the reaction chamber with a frame rate of 1-9 frames per second 
(fps). Data was collected from at least five individual grains, for all samples. 
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Figure 3. Schematic of the membrane immobilization flow-through device. The device consists of a 
pump (1), thermostatted column compartment (T) and a reaction chamber (2). The reaction chamber 
is horizontally divided into two by a membrane filter, on top of which the particles are immobilized. 
Imaging of the particles is enabled though the transparent cover glass. The first inset shows a SEM 
montage image of an individual itraconazole crystal on top of a membrane filter (to scale). The second 
inset shows a close-up SEM image of a membrane.  
 
 
4.2.2 Micro-pellet production (I-III) 
 
Bulk powders of the substances were pelletized using a custom built miniaturized extrusion-
spheronizer. The substances were first ground for 5 minutes, which had been proven in 
preliminary studies to produce a primary particle size of approximately 10 µm. Depending on 
the wettability of a particular substance, an appropriate amount of distilled water was added 
to the micronized powder in order to produce a wetted mass for extrusion. Depending on the 
desired pellet size, the wetted mass was extruded through a perforated steel plate with an 
orifice diameter of 0.3-1 mm. The extrudates were then immediately spheronized into micro-
pellets in the mini-spheronizer. Pellets were stored in a silica gel desiccator until being used in 
an experiment. All pellets were weighed using either an analytical balance (d=0.01 mg) 
(DeltaRange AX105, Mettler-Toledo GmbH, Greifensee, Switzerland) (I), or a mass 
comparator (d=1 µg) (AT21 Comparator, Mettler Toledo, Switzerland) (II-III).  
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4.2.3 UV-spectrophotometry (I) 
 
Liquid samples were analyzed with a UV spectrophotometer (UV-1600PC Spectrophotometer, 
VWR International, Leuven, Belgium). The calibration curves were plotted from samples 
ranging over a ten-fold difference in concentration for ASA (200.0 nm, n = 6, R2 = 0.997), PCM 
(243.9 nm, n = 8, R2 = 1.000) and TP (203.2 nm, n = 10, R2 = 0.999). Samples from three 
different time-points of one ASA, PCM and TP single-particle dissolution experiment were 
measured with and without filtrating. No systematic difference in detected absorbance was 
found between filtered and non-filtered samples, and the concentration difference was on 
average below 1%. Filtration was therefore determined as not being necessary in this case. 
 
 
4.2.4 X-ray powder diffraction (I-III) 
 
To confirm the solid-state transformation of TP anhydrate to TP monohydrate during the 
extrusion-spheronization process, intact and powdered pellets were analyzed with a theta-
theta X-ray diffractometer (D8 advance, Bruker AXS GmbH, Germany). The measurements 
were performed in symmetrical reflection mode using Cu Kα radiation (λ=1.54 Å) over the 
angular range 2.5° to 20°, with a step size of 0.01° and a measuring time of 0.5 s/step. The 
analysis showed a conversion to monohydrate form throughout the pellets. 
 
 
4.2.5 Imaging 
 
Images were captured by USB-microscopes [DigiMicro 2.0 Scale, dnt Drahtlose 
Nachrichtentechnik Entwicklungs- und Vertriebs GmbH, Dietzen-bach, Germany (I-
III)/Gigastone S1-100, Gigastone, CA, USA (IV)], using the accompanying software. In setup 
1 and setup 2 the USB-microscope was used in inverted mode and particles were imaged 
through the transparent bottom of a well plate (I) or on-chip device (II-III). In setup 3 the 
USB-microscope was mounted on an upright Leica DMLB microscope with a Leica 50x (N Plan 
L50X/0.50 – ∞/0/C) objective (IV). The microscopes were calibrated with a micrometer 
graticule before each experiment.  
Morphology of the powder grains and the membrane filter was assessed by scanning 
electron microscopy (SEM) (IV). The samples were adhered to a sample holder using double-
sided carbon adhesive tape and Pt coated in a high vacuum evaporator (Q150TS, Quorum 
Technologies, UK). The samples were then imaged using a Quanta 250 FEG SEM (FEI 
Company, USA).  
 
 
4.2.6 Image and data analysis 
 
Images from setup 1 (I) were generally of good quality and easily segmented, without the need 
for any substantial removal of background noise. After binary conversion the images were 
analyzed using the built in particle size analysis tool of the public domain ImageJ software 
(ImageJ 1.46r, U.S. National Institutes of Health, Bethesda, Maryland, USA). In order to 
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compare the dissolution profiles acquired by UV spectrophotometry and image analysis the 
FDA advocated similarity factor f2,  
 
𝑓2 = 50 × [(1 + (
1
𝑛
) ∑ (𝑅𝑡 − 𝑇𝑡)
2𝑛
𝑡=1
)
−0.5
× 100]                                                                    (22) 
 
and difference factor f1, 
 
𝑓1 = [
(∑ 𝑅𝑡−𝑇𝑡
𝑛
𝑡=1 )
(∑ 𝑅𝑡
𝑛
𝑡=1 )
] × 100                                                                                                           (23) 
 
where n is the number of samples, Rt is the percental amount dissolved of the reference curve 
at time t and Tt is the percental amount dissolved of the test curve, at the same time-point, 
were applied (Costa & Sousa Lobo 2001; FDA 1997). UV-spectrophotometric profiles were used 
as reference in all the calculations. The f2 equation gives the logarithmically converted sum-
squared error of the two profiles, over all data points, and receives a value between 0 and 100 
depending on the similarity. Two dissolution curves are regarded as similar for f2 values over 
50, which indicates an average of less than 10% difference (FDA 1997). The difference factor, 
on the other hand, gives the percentage difference between two curves over all data points, 
with a value below 15 considered as proving equivalency.  
The similarity and difference factors can be calculated from data sets of more than four 
data points (FDA 1997). The values are, however, also susceptible to the number of sampling 
points, with a higher n value leading to better correlation. Therefore, it is suggested that no 
more than one sample, past the point where 85% of the initial mass has dissolved, should be 
used. In this study, however, it was important to compare the dissolution curves over the whole 
range from 0 to 100%. It was therefore decided that ten data points from the mass normalized 
dissolution curves would be enough to allow accurate assessment of the f2 and f1 values, and 
few enough not to cause an improvement of the data. Thus, the data points were calculated 
with 10% increments from fitted curves, so that the final time-point of an experiment was the 
100% data point. 95% confidence intervals were additionally calculated for the collective data 
to visualize and compare the variance of the image and UV analysis data.  
For the processing and analysis of images from setup 2 (II-III) a custom made MatLab 
–script was developed. Using this script, images are first enhanced by removing noise and 
improving contrast. Subsequently, the micrographs are converted into binary and a projection 
area equivalent sphere volume is calculated. Particle characteristics such as aspect ratio and 
perimeter are also acquired (I-III). For setup 3 (IV) a similar MatLab -script was developed. 
Using this script, a ROI containing an individual particle is first selected. The background is 
then removed from the ROI images and the micrographs converted into binary form, using 
local thresholding for each image. Furthermore, a particle is measured and the acquired data 
converted via equivalent circle and spheroid approximations into particle parameters.  
In order to demonstrate the viability of random rotation 2D projection area averaging 
for 3D particle size and shape characterization, a MatLab –script was developed that randomly 
rotates selected 3D objects of known volume and surface-area (III). The script captures 1000 
2D projection images in a sequence of every 100th random orientation. A projection surface 
area equivalent sphere approximation is subsequently performed and the acquired sphere 
surface-area and volume values compared with known values. The random rotation simulation 
data was also used to determine the required minimum number of images for reliable shape 
estimation, determined as the point where the moving average of the subsequent simulation 
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volume values decreased below 5% of the total average. The simulation was performed on 
several pharmaceutically relevant shapes, including equidimensional, elongated and flat 
morphologies with rounded and angular edges.  
A real-time determination point was estimated in two ways. A 100 data-point moving 
average value was used in setup 2 (II-III). The early detection point was chosen as the moving 
average value, where the relative standard deviation (%RSD) of 100 moving average values 
decreased below the standard experimental error of 5. For experiments in which less than 200 
data-points were acquired, the end-point of an experiment was considered as the 
determination time point. For setup 3, a two-sample (n=10) t-test analysis on the slope of the 
linear regression line of the decreasing particle radius was used. The slope was assumed to 
have reached steady state when the p value of the t-test analysis decreased below 0.05 
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5 Results and discussion 
 
 
5.1 Single-particle dissolution rate (I) 
 
 
5.1.1 Equivalent sphere volume approximation  
 
As seen in Equations 14 and 20 the dissolution rate of a compound can be determined either 
from the cumulative increase in the solvent or from the cumulative mass released from the 
solid. Accordingly, the dissolution rate of an individual dissolving particle was calculated based 
on image analysis particle size decrease data. The initial mass of a pellet was acquired by 
weighing and the density of the pellets were assumed to be uniform throughout. This 
assumption was based on interpellet density data, which was found to be very similar, therefore, 
also the intraparticle density was assumed to be uniform. Moreover, it has been shown that the 
density of crystalline masses does not affect the dissolution rate, and that the density of pellets 
is primarily dependent on the density of the bulk material used in production (Löbmann et al. 
2014; Sousa et al. 2002; Parrott et al. 1955). The use of pure substance pellets also meant that 
the relationship between decrease in particle size and mass released was directly proportional.  
As the particles in setup 1 dissolved under stagnant conditions, and were imaged from 
only one angle, this meant that the analyzed particles were preferentially orientated at the 
moment of image capture (see section 2.4.1). However, since spheres show the same two-
dimensional projection in all directions, the angle of observation is not relevant. The sphere is 
also the geometrical shape with the lowest surface area per volume ratio, and thus with the 
lowest surface energy. It is therefore expected that the spherical shape is the most 
geometrically stable and, accordingly, the shape which will dissolve most isotropically. This 
was found to be the case through the assessment of average aspect ratios of the particles. In 
line with results from other single-particle studies, the aspect ratio of a particle remained 
practically unchanged during the dissolution process, which indicates the retaining of a 
spheroidal shape throughout the experiments (Marabi et al. 2008; Parrott et al. 1955). 
As was shown by Østergaard and coworkers, the concentration around a dissolving 
particle, in a stagnant liquid, is always highest towards the bottom of the dissolution vessel 
(Østergaard et al. 2011). This would cause varying concentration gradients and convection 
around the single pellets, which would lead to anisotropic dissolution. No significant increase 
in the aspect ratios during the single-pellet studies were, however, observed in this study. 
Isotropic dissolution could therefore be assumed, justifying the use of an equivalent sphere 
approximation when calculating particle volumes (Allen 1990). 
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5.1.2 Comparison of UV analysis and image analysis data 
 
Data of the individual particles is presented in Table 2. It can be seen that the correlation data 
of the ASA and PCM pellets are very good, with average ±sd R2 values of 0.988 ±0.013 and 
0.989 ±0.01, and average f2 values 76 ±27 and 80 ±13, respectively (Eqs 22 and 23). The f2 and 
f1 values are even better, around 90 and 2, respectively, for two out of three ASA and PCM 
single-particle experiments, demonstrating almost identical dissolution profiles between 
image analysis and UV-spectrophotometric data (Figure 4).  
 
Table 2. Correlation of image and UV analysis data from the single-pellet experiments of acetylsalicylic 
acid (ASAX), theophylline monohydrate (TPX) and paracetamol (PCMX), as well particle characteristics. 
The similarity (f2) and difference factors (f1) indicate a very high correlation between image and UV 
analysis data 
Experiment R2 f2 f1 Mass (mg) Density (mg/mm3) 
ASA1 0.974 45 15 0.20 0.67 
ASA2 0.993 89 2 0.41 0.64 
ASA3 0.998 94 1 0.66 0.62 
TP1 0.980 81 3 0.45 0.66 
TP2 1.000 96 1 0.85 0.67 
TP3 0.996 96 1 0.27 0.67 
PCM1 0.997 91 2 0.33 0.75 
PCM2 0.971 65 6 0.21 0.80 
PCM3 0.998 83 3 0.51 0.79 
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Figure 4. (a) A typical single-pellet image. Dissolution profiles of image and UV analysis data from 
paracetamol single pellet experiment (PCM1) (R2=0.997) (b), theophylline monohydrate single pellet 
experiment (TP2) (R2=1.000) (c), and acetylsalicylic acid single pellet experiment (ASA3) (R2=0.998) 
(d). Copyright © (2014) Elsevier B.V., modified with permission from publication (I). 
 
 
As the calibration curve for TP was produced using TP anhydrate, which is known to 
recrystallize as TP monohydrate after wetting, a correction factor of 1.0999, i.e. the MW ratio 
of TP anhydrate/TP monohydrate, was used to correct the UV absorbance data (Aaltonen et al. 
2006). Using the correction factor data from all TP pellets showed very high similarity, with 
average f2 and f1 values of 91 ±9 and 2 ±1, respectively (Table 2).  
The cause of the deviating variance of some of the profiles can be speculated upon. Image 
analysis data of PCM pellets had a narrower distribution, compared to UV-spectrophotometric 
data. This was a result of one deviating UV dissolution profile (PCM2) (Table 2). Accordingly, 
for ASA collective data, one deviating UV dissolution profile (ASA1) caused a slightly wider 
confidence interval for the chemical analysis data. The source for the weaker ASA1 and PCM2 
correlations could be the pellet masses, which were the smallest of the three studied particles, 
consequently producing the most dilute samples. Chemical analysis of dilute samples is 
therefore assumed to be the main cause of error for these substances. 
For TP monohydrate the case was reversed, with the image analysis data having a larger 
variance, due to the one deviating (TP1) dissolution profile. The data from experiment TP1 
could have been predicted to be the most accurate of the three TP monohydrate pellets, since 
it had the lowest aspect ratio (1.09 ±0.07) and the highest roundness (0.92 ±0.05) throughout 
the experiment. However, the weight normalized TP1 dissolution curve from image analysis 
a
  a 
b
  a 
c
  a 
d
  a 
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data showed a slightly slower dissolution rate than absorbance data, and it is therefore 
assumed that the weighed mass of the TP1 pellet was the main cause of error.  
In summary, the dissolution profiles acquired by traditional UV spectrophotometric 
analysis of liquid samples and image analysis of the dissolving pellets were practically identical. 
This result justifies the use of image-based microscopy as an analytical method for single-
particle dissolution studies. The semi-static setup could be used, for example, to study the 
dissolution of inhalation particles or particles intended for buccal administration. As stated in 
chapter 2.4, optical microscopy could prove an optimal analytical tool for drug substances, as 
image analysis does not depend on the chemical properties of the analyzed substance. Due to 
this non-specific nature, image analysis could be used to study the whole domain of chemical 
space represented by NMEs and existing drugs. While image analysis has been used before in 
dissolution rate assessment, this is the first time, to the best of my knowledge, that it has been 
evaluated by comparison to existing analytical methods. The positive result enabled further 
extension of the single-particle methodology. 
 
 
5.1.3 Single-particle intrinsic dissolution rate (SIDR) (III) 
 
While IDRs are generally determined from the dissolution rate of a constant surface area, 
continuous monitoring and determination of a changing surface area of individual particles is 
an equivalent technique. Evidence of this was given already in single-particle studies 
conducted by Parrot and coworkers (Parrott et al. 1955). As sink conditions are required for 
facilitated determination, the flow through system of setup 2 was used in these studies. 
Additionally, in order to accurately determine the IDR, the effective surface area of the 
dissolving particle has to be known. An advantageous feature of setup 2 is that a random 
projection 3D particle morphology characterization can be made from the freely rotating pellet. 
It was observed in the random orientation simulation studies, that the particle surface-area 
was directly acquired from simulation projection area equivalent sphere surface area 
calculations, with an average deviation of 3.9%. This means that no extra shape factor needs to 
be considered when determining the SIDR effective surface area of a randomly rotating particle, 
thus, minimizing error sources.  
In contrast to the sphere (I), the volume was not directly acquired from projection area 
equivalent sphere volume calculation for non-spherical rotating particles. Using random 
orientation circularity (c), 
 
𝑐 =
4𝜋𝐴
𝑝2
                                                                                                                                                      (24) 
 
as a proxy for average particle sphericity, where A is the projection surface area and p is the 
projection area perimeter, the actual volume was determined to within on average 10.9% (Blott 
& Pye 2007; Cox 1927). Thus, it is possible to acquire both the particle surface area and volume 
throughout experiments in the vortex particle trap.  
It can be noted that the volume data improved after circularity correction for all other 
particle shapes except the sphere. Theoretically a perfect sphere should produce a 1:1 
equivalency of the equivalent sphere volume and true volume (I). The discrepancy with 
circularity correction can be explained by the effect of image analysis, as the pixelated 
perimeter will differ from the perfect sphere perimeter and will therefore distort the data, 
instead of correcting it. However, a drug particle will never be perfectly spherical and, thus, the 
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issue is purely theoretical. A practical weakness of characterizing 3D morphologies based on 
2D projection images is that depressions and hollows in particle surfaces remain invisible. This 
is, however, an issue in most projection based characterization applications, but is considered 
to be less pronounced in dissolution studies, as dissolving particles strive towards surface 
energy minimization and, thus, increasing convexity during the dissolution process. 
Highly reproducible SIDRs (Relative standard deviation [%RSD] = 9.4) were acquired 
for the eight studied substances, using the method established for volume and surface-area 
quantitation through the random orientation simulation. In line with previous research, the 
correlation between SIDR and literature equilibrium solubility values is excellent, with the 
exception of citric acid (Table 3 and Figure 5) ((II); Shah & Nelson 1975; Hamlin et al. 1965; 
Higuchi et al. 1965; Parrott et al. 1955).  
 
Table 3. Substance, single-particle intrinsic dissolution rate (SIDR) and real-time data 
 
 
 
Substance 
Particle 
mass 
(µg) 
Equilibrium 
solubility 
(mg/mL)a 
SIDR 
(mg/cm2/min)a 
Average SIDR 
(mg/cm2/min)a 
Real-time SIDR 
(mg/cm2/min) 
% 
of dissolution 
profile needed 
Naproxen 
14 
1.6×10-2 
1.9×10-3 
1.8×10-3 1.9×10-3 20.8 31 1.7×10-3 
38 1.9×10-3 
Furosemide 
68 
3.6×10-2 
4.3×10-3 
3.7×10-3 3.7×10-3 23.5 121 3.7×10-3 
158 3.0×10-3 
Hydrocortisone 
47 
3.2×10-1 
2.7×10-2 
2.8×10-2 1.9×10-2 20.0 50 3.0×10-2 
60 2.6×10-2 
Acetylsalicylic 
acid 
36 
4.6 
4.8×10-1 
4.3×10-1 3.7×10-1 18.0 43 4.1×10-1 
78 3.9×10-1 
Theophylline 
309 
8.33 
5.9×10-1 
6.2×10-1 5.1×10-1 32.8 317 6.2×10-1 
25 6.5×10-1 
Acetaminophen 
202 
14 
1.2 
1.2 1.1 31.7 238 1.4 
431 1.0 
Sodium 
chloride 
548 
317 
38 
36 N/A N/A 657 35 
747 35 
Citric acid 
156 
592 
40 
36 N/A N/A 210 34 
259 35 
Average       24.5 
aIn water at 20-25 °C, equilibrium solubility values from (US National Library of Medicine 2014; O’Neil 
2001).  
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Figure 5. Single-particle intrinsic dissolution rate (SIDR) profiles of all studied substances. A 
progressive gravitation toward the average is observed, which allows earlier termination of the SIDR 
measurement for real-time high-throughput applications. The effect of intermittent rotation is depicted 
in the 78 µg acetylsalicylic acid SIDR profile (e). Copyright © (2015) American Chemical Society, 
modified with permission from publication (III). 
 
 
In the random orientation simulation, an average of 33 ±13 random projection images 
were needed to move within a variance of 5% of the total average. This showed that a minimum 
of around 50 images would be required for accurate SIDR determination. Due to the very rapid 
dissolution rate of citric acid, the average number of images from these measurements was 22. 
Thus, it can be concluded that citric acid SIDR values are not as reliable as for the other 
substances. If citric acid is omitted from the comparison with literature equilibrium solubility 
values, a R2 value of 0.999 is achieved for the linear fit intercepting origin (Figure 6a). As seen 
in Figure 5, the continuous rotation of the dissolving particles results in an evenly fluctuating 
profile around the average SIDR value. On the other hand, the effect of intermittent rotation 
on the SIDR profile, as seen with the 78 µg ASA particle (Figure 5e), leads to increased 
deviation from the average, and longer determination times.  
a b
  a 
c
  a 
d
  a 
e
  a 
f
  a 
g
  a 
h
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Figure 6. (a) Comparison of single-particle intrinsic dissolution rate (SIDR) and literature equilibrium 
solubility (logS) values. Logarithmic axes are used for clearer depiction. A high linear correlation 
(R2=0.999) is observed, except for the citric acid data point in the upper right corner of the graph. (b) 
Relationship between flow-rate and SIDR in the optofluidic flow-through device. Paracetamol (●), 
R2=0.995. Acetylsalicylic acid (●), R2=0.989. Hydrocortisone (●), R2=0.989. Copyright © (2015) 
American Chemical Society, modified with permission from publication (III). 
 
 
The linear relationship between angular velocity of the rotating disc and measured DIDR 
of the compendial rotating disc Wood's apparatus is well reported (Tsuji et al. 1978; Shah & 
Nelson 1975; Levich 1962). Differing liquid flow dynamics have also been shown to produce 
variation in the IDRs for the same substances in different flow-through devices (Hulse et al. 
2012; Lehto et al. 2008). Thus, the effect of flow rate was determined for setup 2, in order to 
allow comparison between the SIDR method and other flow-through apparatus, as well as the 
conventional DIDR apparatus. The characterization of the impact of flow-rate on SIDRs 
produced a linear relationship for the three studied substances, with R2 values of 0.995, 0.989 
and 0.989 for PCM, ASA and hydrocortisone, respectively (Figure 6b).  
When high-throughput application is the goal, measurements should be automated and 
analysis performed in real-time (Kerns 2001). When using the %RSD of 5 as a threshold, an 
average of 24.5±12.1% of the total dissolution curve was needed for reliable SIDR 
determination (Table 3). This can be compared to conventional DIDR studies, where data from 
the first 10% of a dissolution curve is usually required for IDR determination (USP 2015). The 
result is the average of six substances as citric acid and sodium chloride where omitted from 
the analysis due to the intrinsic rapidity, between 21-68 seconds, of these measurements 
(Figure 5). The average difference between the real-time and the final SIDR value was 15.0% 
for the six substances, demonstrating the possibility of using the earlier determination point 
for more rapid analysis. When considering the final data point of the citric acid and sodium 
chloride SIDR measurements as the determination point, a mean measurement time of 2 hours 
was required for real-time SIDR determination of all substances, with a median of 8.6 minutes.       
While kinetic solubility accuracy, i.e. within an uncertainty of 1.7 log units, of the SIDRs 
is achieved in an average of 6 minutes, this uncertainty is, as discussed in section 2.3.2.2, not 
adequate for informed decision-making (Stuart & Box 2005). However, the very small sample 
size of as little as 14 µg gives a clear advantage of the SIDR method when compared to other 
miniaturized IDR methods (Hulse et al. 2012; Avdeef 2008). Also, SIDR measurement 
produces particle size and shape dependent data, which allows the possible extrapolation of 
the acquired data into other particle shape(distributions), size(distributions) and effective 
surface areas. Furthermore, a general trend of increased data accuracy and acquisition rapidity 
 a
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b
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of SIDR data was observed, with decreasing initial particle size of the pellets. This indicated 
that further miniaturization could lead to a further decrease in measurement times.  
 
 
5.2 Single-particle physicochemical profiling (II, IV) 
 
 
5.2.1  Solubility (II, IV) 
 
As reviewed in section 2.3.2.2, all methods for measuring the solubility of substances are based 
on multiparticle systems and determined in the presence of excess solid. However, according 
to the generally accepted diffusion layer dissolution rate model (Eq. 14), the difference between 
saturation concentration and bulk concentration is the rate limiting factor in a dissolution 
process (Noyes & Whitney 1897). In order to accurately determine the diffusion layer of a 
particle, the size and shape of the particle have to be reliably determined. One way of achieving 
this is through single-particle analysis, thus avoiding population based estimations and other 
error sources arising from e.g. aggregation and agglomeration of multiparticle systems (Hulse 
et al. 2012; de Villiers 1996). Under the sink conditions produced in the flow-through cell of 
setup 2, the concentration gradient in the diffusion layer, at the solid-liquid interface, goes 
from saturation concentration adjacent to the solid surface to zero outside the diffusion layer 
(Figure 7) (Higuchi 1967; Nernst 1904). Consequently, equilibrium solubility becomes the rate 
limiting factor of dissolution and can be determined. 
 
 
Figure 7. According to the diffusion layer model, equilibrium solubility S is assumed at the solid-liquid 
interface (black surface). A diffusion layer of thickness h (particles) exists immediately adjacent to the 
dissolving solid surface, outside of which a uniform bulk concentration Cb is assumed. The blue particles 
in the image represent dissolved molecules. Under sink conditions the bulk concentration is negligible 
and thus the equilibrium solubility at the solid-liquid interface becomes the rate limiting factor of 
dissolution, and can be determined. Copyright © (2015) American Chemical Society, modified with 
permission from publication (II). 
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By rearranging the Hixson-Crowell cube root equation (Eq. 18), an expression for 
solubility, based on single-particle dissolution, can be found. Using the expression for the 
dissolution rate constant K in Equation 19 (Wang & Flanagan 1999), the estimation of the 
diffusion coefficient Dc from Equation 16 (Al-janabi 1990), and approximating the diffusion 
layer thickness to 30 µm (Hintz & Johnson 1989), the rearranged equation gives, 
 
𝑆 =
𝜌(𝑤0
1 3⁄ −𝑤𝑡
1 3⁄ )𝑀𝑊1 3
⁄
(
4𝜋𝜌
3 )
1 3⁄
𝑡
                                                                                                                           (25) 
 
As can be appreciated from the above equation, the only primary data needed for determining 
the solubility of a substance, from the dissolution rate, is the initial weight of the dissolving 
particle and the molecular weight of the dissolving substance. In accordance with image-based 
determination of single-particle dissolution rate (I), the pellet density is acquired from the 
initial mass of the pellet divided by the projection area equivalent volume (II). For crystals, the 
mass was calculated based on molecular weight of a compound and true density of the crystal, 
using a spheroid approximation for the crystal volume (IV). The crystal density for all organic 
and inorganic compounds were acquired from literature, whereas the crystal density of 
recombinant human insulin was acquired as the inverse of the partial specific volume of the 
protein monomer (Massera & Hupa 2014; Gbureck et al. 2007; Murphy et al. 1998; Allen 1990).  
As was reviewed in section 2.3.2.2 the determination of solubility based on bulk solvent 
concentrations, requires several hours or even days to reach an equilibrated state between the 
solid and the dissolved molecules (Alsenz & Kansy 2007; Sugano et al. 2007; Lipinski et al. 
1997). Contrarily, the buildup of the diffusion layer, for diffusivities common to drugs, has been 
shown to take approximately 0.02-2 s (Weiss 1996). One has to bear in mind that the solubility 
thus determined will be dependent on the solid form of the dissolving substance. For the most 
stable polymorph of a pure drug substance, the solubility determined will be the equilibrium 
solubility of the substance. If an unstable, a metastable form, salt, solvate or cocrystal is 
analyzed, the resulting solubility value will be the apparent solubility of that particular solid 
form. Therefore, in order to achieve values comparable to literature values, the substances 
chosen for this study were known not to undergo solid state transformations during the time 
range and in the environment of the dissolution process.  
However, going forward it might be advantageous for drug development settings to study 
the apparent solubility of metastable forms. In salt and solid form screening, one aim is to 
improve the bioavailability of a substance by increasing the dissolution rate and apparent 
solubility (Sugano et al. 2007; Huang & Tong 2004). It may therefore be more valuable to study 
the apparent solubility of substances and to assess the stability of metastable forms during 
physiologically relevant conditions and timescales, such as the MITT of 1-3 h (Bhattachar et al. 
2006; Dressman et al. 1998).  
It is also well known that the diffusion layer thickness of a dissolving solid is affected by 
the hydrodynamic environment of the dissolution system (Levich 1962). Therefore, the data 
obtained from a specific dissolution system will be dependent on the specific conditions of that 
system, such as flow-rate of the solvent, which are reflected in a system constant. The system 
constant (ks = 7.95 x 103) for setup 2 was acquired from the log-log linear correlation (R2=0.998) 
between single-particle equilibrium solubility values and equilibrium solubility data from 
literature. By inserting this value into Equation 25,  
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𝑆 = 7.95 × 103
𝜌(𝑤0
1 3⁄ −𝑤𝑡
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3 )
1 3⁄
𝑡
                                                                                                (26) 
 
it was possible to convert the measured single-particle solubility values into equilibrium 
solubility, achieving an average difference of 7.8% when compared to literature values and a 
RMSE of 0.07 log units for the single-particle solubility values (Table 4). The solubility values 
acquired in this way under unbuffered conditions, are the native equilibrium solubilities of the 
substances. A typical single-particle solubility profile obtained by Equation 26 is shown in 
Figure 8. It can be seen that a fluctuation around the equilibrium value takes place during the 
dissolution process, with the initially wide fluctuation equilibrating after a period of time. 
 
Table 4. Comparison of single-particle and literature equilibrium solubility values 
Substance 
Single-particle 
equilibrium solubility  
(mg/mL) ± sd 
Literature  
equilibrium solubility  
(mg/mL) 
Difference from average  
% 
Paracetamol 12.9 ± 2.2 14.0 - 8.0 
Acetylsalicylic  
acid 4.57 ± 0.28 4.60 - 0.7 
Citric acid monohydrate 626 ± 50 592 + 5.7 
Furosemide 0.033 ± 0.011 0.040 - 7.4 
Hydrocortisone 0.29 ± 0.02 0.32 - 6.3 
Naproxen 0.019 ± 0.003 0.016 + 20.1 
Sodium chloride 383 ± 10 317 + 6.8 
Theophylline 
monohydrate 7.75 ± 0.23 8.33 - 6.9 
Average (absolute)   7.8 
 
 
While more data is retrieved from more poorly soluble substances, an increased 
variability with decreasing solubility was observed, due to the longer dissolution times. A 
simple explanation is the relative increase in measurement error when studying small-scale 
changes. In a parallel experiment it was not possible to retrieve a dissolution curve for the low 
solubility single-particles using UV-spectrophotometric analysis. This was probably due to the 
adsorption and/or absorption of the low quantities of the hydrophobic substances to the tubing 
of the flow-through system, and shows the critical importance of minimizing error sources 
when using miniaturized methods. The use of image-based analysis is one way to achieve this, 
through the avoidance of potential error sources such as liquid sample handling and the 
influence of adsorption or absorption of substances to hydrophobic surfaces of the apparatus 
and equipment (Paakkunainen et al. 2009; Faller & Ertl 2007).  
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Figure 8. Single-particle solubility profile. The dots show individual single-particle solubility values 
acquired through the reorganized Hixson-Crowell cube root equation (Eq. 26). Data-points up to 290 
seconds, with a higher range of fluctuation, are omitted in order to produce a more focused view. The 
moving average (n=100) represents the real-time characterization. In the inset, a close-up of the 
equilibration is visualized with the dashed vertical line indicating the real-time determination point. At 
this time-point, the equilibrium solubility value is on average within 8% of the final value for all 
substances. Copyright © (2015) American Chemical Society, reprinted with permission from publication 
(II). 
 
 
In the trapping efficiency characterization of setup 2, a linear relationship between 
particle size and average deviation of the center of mass was observed for non-dissolvable 
particles (III). The focusing efficiency of the device is, thus, particle size dependent, with 
smaller particles being more effectively positioned. This is an advantage, as higher 
magnifications with narrower fields of view can be used for more accurate data acquisition, 
when studying smaller particles. However, particles below 100 µm tend to exit the device with 
the flow, thus posing a lower limit on the single-particle method of setup 2. The two other main 
limiting factors of setup 2 are the initial micro-pellet production and the initial mass 
determination of the individual particle.  
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5.2.2 Solubility, lipophilicity and charge state (IV) 
 
In order to address the issues of setup 2 and to evaluate the possibility of more rapid analysis 
with decreasing particle size (III), setup 3 was developed. As described in section 4.2.1.3, 
individual particle grains are immobilized by the liquid flow toward a filter membrane, where 
they can be imaged. Similarly to setup 2, dissolved molecules are continuously extracted from 
the reaction chamber and the concentration profile around the individual particles is kept 
constant under sink conditions. Again, using Equation 25 the system constant for setup 3 was 
determined by correlating image analysis equilibrium solubility data with literature 
equilibrium solubility data (n=60, R2=0.963), using 11 organic compounds of known water 
solubility, spanning over 7.5 orders of magnitude at the same temperature (Fig. 9).  
 
 
Figure 9. Calibration curves determined based on the diffusion layer dissolution rate equation (H-C), 
the density corrected slope of the decreasing projection area (kAρ) and the density corrected slope of the 
decreasing projection area equivalent circle radius (krρ). It can be seen that the slope of the calibration 
curves using different readout parameters do not differ substantially, with the density corrected radius 
and the dissolution rate equation calibration slopes being practically identical. 
 
 
Additionally, it was found that the decreasing projection area slope, as well as the slope 
of the decreasing particle radius, gave almost similar correlation as the solubility calculated 
based on the dissolution rate equation (Fig. 9). The projection area was directly acquired from 
pixel data and the radius was calculated based on equivalent circle approximation. A slight 
improvement in the correlation was observed when multiplying the slope values with the 
respective crystal density of the studied material. Crystal density is an obvious affecting factor, 
as it directly relates to the mass released from the respective particle volume decrease. 
However, the difference between density corrected and non-density corrected data was on 
average 0.27 log units and thus within the range of uncertainty of the calibration data. This 
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implies that a reasonable estimation of the solubility can be acquired for a substance, even in 
cases where material properties are not known a priori, based on solely particle size data. The 
power of experimental measurement is highlighted by the fact that for two of the model 
compounds, indomethacin and probenecid, only 4% and 2%, respectively, of specifically 
trained computer models succeeded in accurately predicting the solubility (Hopfinger et al. 
2009). 
In order to demonstrate the non-specific and wide applicability of the method, the 
solubility in PBS solution was determined for additionally three model compounds of diverse 
chemical structure and properties; recombinant human insulin, dicalcium phosphate 
dihydrate (CaHPO4·2H2O, DCPD, brushite) and bioactive glass S53P4. The difference between 
the single-particle values and literature values for all substances was on average 0.3 log units 
and the uncertainty of the single crystal solubility values 0.15±0.06 log units, which is 
substantially less than the range of uncertainty of current high-throughput and in silico 
methods (Tetko et al. 2009; Mannhold et al. 2009; Stuart & Box 2005; Jorgensen & Duffy 
2002).  
As the solid form of a compound has not necessarily been chosen at the discovery stage, 
and variation in crystal forms are common, an uncertainty of 0.3 log units, i.e. a twofold error, 
can be considered the highest achievable accuracy for crystalline material in drug discovery 
settings (Sugano et al. 2007; Kerns 2001). This is because the difference in solubility between 
different polymorphs and hydrate/anhydrate forms of the same drug substance has been found 
to generally differ twofold or less, while the difference in solubility between amorphous and 
crystalline material is more diverse and can show up to hundredfold differences (Pudipeddi & 
Serajuddin 2005; Huang & Tong 2004). Amorphousness and crystallinity can, however, be 
assessed by polarized light microscopy and the apparent solubility between the two can 
therefore be easily differentiated (Wu et al. 2014; Sugano et al. 2006).  
In order to demonstrate HCA applicability of setup 3, the native, intrinsic and 
equilibrium solubility, dissolution rate, pKa, logP and logD were determined for model 
substance indomethacin (Fig. 10). Indomethacin is a weakly acidic organic drug molecule, 
commonly used as a model compound for poorly soluble drugs. The pH-solubility profile was 
measured in aqueous buffers over the physiologically relevant range of pH 2 to 9. Additionally, 
the equilibrium solubility was determined in three simulated body fluids (fasted state 
simulated intestinal fluid, pH 6.5; fed state simulated intestinal fluid, pH 5; fasted state 
simulated gastric fluid, pH 1.6) as well as two commonly used organic solvents (ethanol and 
octanol) (Table 5). It can be observed from Figure 10, that the solubility increases linearly with 
the increasing ratio [𝐴−]/[𝐻𝐴] of the acidic moiety, according to Equation 8. This is however 
not always the case and the application of the Henderson-Hasselbalch relation, in order to 
calculate solubilities, based on the intrinsic solubility, has been found to be limited, stressing 
the need for experimental determination (Bergström et al. 2004). The pKa of 4.4 for 
indomethacin was acquired from the intersection of the mean intrinsic solubility value (S0, pH 
2-3) and the regression line of the linearly increasing pH-solubility profile. As the aqueous 
solubility of the unionized form as well as the solubility in octanol were acquired, it was 
possible to determine the logP value of indomethacin as 4.1, using Equation 11. Finally, from 
logP, pKa and pH data, the logD profile was determined using Equation 12. The parameters 
are in high correlation with theory and literature data (Fig. 10, Table 6). 
 Thus, by only observing and characterizing one variable, i.e. the particle size decrease of 
an individual crystal, it is possible to mine, in a HCA manner, seven fundamental materials 
characteristics for a substance. The indomethacin profile was acquired from the analysis of less 
than 400 ng of compound in total (n=69). Using HCA of individual crystals, the total amount 
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analyzed for a full solubility-lipophilicity-charge state profile is thus above one order of 
magnitude less than the amount required for one experiment in one solvent using existing state 
of the art techniques (section 2.3.2.2). 
 
Table 5. Indomethacin solubility profile 
Solvent pH 
ClogSparticlea 
(g/L) 
Equilibrium solubility, Sb 
(g/L) 
RSD (%) 
Aq. Buff. 9.0 1.16 × 100 (n=6) 1.45 × 101 55.2 
Aq. Buff. 8.0 -1.97 × 10-2 (n=7) 9.56 × 10-1 16.5 
Aq. Buff. 7.4 -6.60 × 10-1 (n=5) 2.19 × 10-1 48.9 
Aq. Buff. 6.8 -1.24 × 100 (n=5) 5.73 × 10-2 50.1 
Aq. Buff. 5.8 -1.86 × 100 (n=5) 1.39 × 10-2 35.0 
Aq. Buff. 4.5 -3.13 × 100 (n=5) 7.50 × 10-4 31.5 
Aq. Buff. 3.0 -3.46 × 100 (n=5) 3.48 × 10-4 10.1 
Aq. Buff. 2.0 -3.54 × 100 (n=5) 2.89 × 10-4 18.8 
FaSSIF 6.5 -1.84 × 100 (n=6) 1.46 × 10-2 34.2 
FeSSIF 5.0 -2.32 × 100 (n=5) 4.78 × 10-3 26.7 
FaSSGF 1.6 -3.51 × 100 (n=5) 3.08 × 10-4 19.3 
Ethanol n/a 1.16 × 100 (n=5) 1.46 × 101 14.4 
Octanol n/a 6.37 × 10-1 (n=5) 4.34 × 100 8.22 
Average    28.4 
aCalculated values based on dissolution rate equation calibration data, b10(𝐶𝑙𝑜𝑔𝑆𝑝𝑎𝑟𝑡𝑖𝑐𝑙𝑒). Calculated logS 
(ClogSparticle). 
 
 
 
Table 6. Indomethacin lipophilicity/charge state profile 
Parameter Single-crystal Literature ref. 
pKa 4.4 4.5a 
logP 4.14 4.27b 
logD7.4 1.2 1.3c 
a(Hansch et al. 1995), b(O’Neil 2001), c(Barton et al. 1997). 
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Figure 10. Solubility-lipophilicity-charge state profiling and impact. (a) The equilibrium solubilities 
(S) measured for a diverse set of organic, inorganic, and biological materials over a solubility range of 
7.5 orders of magnitude. The LogS axis includes commonly used qualitative solubility ranges. (b) A 
complete solubility-lipophilicity-charge state profile for model compound indomethacin. Analyzing less 
than 400 ng of compound in total (n=69), the intrinsic (S0) and equilibrium solubility, dissolution rate, 
pKa, logP and logD (– –) were acquired; using organic solvents, aqueous (), as well as simulated 
physiological solutions (). The parameters are in high correlation with theory (– –) and literature 
values (Table 6). (c) As solubility and lipophilicity determine the physiological and environmental 
activity and distribution of materials, HCA can be applied in determining for example local or systemic 
absorption, toxicity and therapeutic effects, as well as the environmental impact of compounds. 
Automated image-based analysis further enables rapid screening, with minimal compound 
consumption and handling of valuable and potentially hazardous compounds.   
 
 
Using statistical real-time verification (t-test, p ≤ 0.05), it was possible to terminate the 
individual measurements early on with a sufficient degree of accuracy. At the real-time 
determination point, the particle radius decrease slope differed on average 0.21 log units from 
the regression line slope of a full experiment. The uncertainty within the range of the RSD of 
the complete measurements and, again, substantially less than the uncertainty of standard 
methods (Tetko et al. 2009; Mannhold et al. 2009; Stuart & Box 2005; Jorgensen & Duffy 
2002). With an image acquisition rate of 1 fps, the steady slope was reached generally within 
30 seconds or after around 25 data points, regardless of the studied substance. Therefore, 
rather than being material dependent, the measurement time seems to be controlled by data 
acquisition speed and, thus, by the frame rate and resolution of the imaging sensor. For the 
least soluble compound studied, itraconazole, steady state was reached in 11 seconds with an 
image acquisition rate of 9 fps (Fig. 11).  
 
a
  a 
b
  a 
c
  a 
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Figure 11. Itraconazole solubility profile. Calculated based on the decreasing slope of the individual 
particle radius. With an image acquisition rate of 9 fps the steady state (t-test, p≤0.05) real-time 
termination point was achieved after 0.18 min (n=96). 
 
 
The average initial mass of the individual crystals analyzed was 5.0 ng. The substance 
needed for individual measurements using image-based HCA is thus above three orders of 
magnitude less than what is required in current state of the art miniaturized methods (section 
2.3.2.2). The gain is much higher when comparing to standard methods, which operate in the 
mg and g range (OECD 2016a; OECD 2016b). Substantial advancements of the method 
capabilities can also be foreseen, as techniques for the determination of particle size and mass 
on the nanometer and femtogram scale already exist (Hell 2007; Greenbaum et al. 2012; Burg 
et al. 2007). Moreover, the smallest change in mass between two samples of ten after reaching 
steady state was 116 fg. This sets the limit of quantitation of image-based analysis on the same 
level as that of current advanced analytical methods, such as MS (Ternes 2001).  
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6 Conclusions 
In this thesis the applicability of image-based microscopy of single-particles was explored as a 
novel method for physicochemical characterization of drugs.  
First, it was shown that data obtained by optical image-based digital microscopy and UV 
spectrophotometry produce practically identical dissolution rate data with equal variance for 
dissolving individual particles of model acidic and basic drug compounds. Consequently, it is 
proposed that image analysis can be used, on its own, as a viable analytical technique in single-
particle dissolution studies 
Next, a single-particle trapping device was developed, wherein individual drug particles 
can be continuously imaged under constant flow conditions. Using this device it was shown 
that optical monitoring combined with image analysis can be used for rapid real-time 
determination of IDR from continuously changing effective surface areas of dissolving 
individual microparticles.  
The method was then further extended to determine the equilibrium solubility of drugs. 
While solubility is generally determined from bulk solutions after long incubation times, it was 
shown that the equilibrium solubility can be rapidly determined from individual pure-
substance particles based on the diffusion layer theory and image analysis.  
Finally, a second device was developed and the method further miniaturized and 
extended to acquire seven fundamental physicochemical properties of matter, i.e. the native, 
intrinsic and equilibrium solubilities, dissolution rate, pKa, logP and logD, with femtogram 
range accuracy, from individual nanogram crystals. Using the method, it is possible to acquire 
a complete pH-solubility profile for an unknown material of unknown composition in aqueous 
buffers, in addition to the solubility and dissolution rate in any transparent organic, aqueous 
or physiological solvent, with individual measurements of less than 30 seconds.  
In summary, these results strongly suggest that image-based analysis of materials could 
be applied in HTE applications, as speed can be increased and substance consumption reduced, 
while maintaining analytical integrity. As in the case of kinetic solubility assessment, the non-
specific nature of image-based analysis makes the method applicable to the whole range of 
chemical space of drugs, in various organic, aqueous and physiological solvents. In line with 
state of the art miniaturized methods such as CE, the nanogram range substance consumption 
and sub-minute range automated analysis makes the single-particle method applicable at the 
very beginning of the drug discovery process. Furthermore, the high accuracy as well as low 
detection limit and data variability, comparable to those of current ‘gold standard’ 
measurements and advanced analytical methods, indicates that image-based analysis could 
bridge the gap currently separating throughput and quality in physicochemical analysis. With 
automation and parallelization of the single-particle measurements, all the required criteria 
for HTE methods would be achieved. 
Finally, the possibility of acquiring solubility, dissolution rate, lipophilicity and pKa using 
a single analytical method could significantly simplify and speed up accurate data acquisition, 
leading to faster and more informed decision-making and, ultimately, better and more 
affordable drugs. 
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